<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1366889</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2024.1366889</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Phytochemical analysis and biological investigation of <italic>Cheilanthes tenuifolia</italic> (Burm.f.) Swartz</article-title>
<alt-title alt-title-type="left-running-head">Juhi et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2024.1366889">10.3389/fphar.2024.1366889</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Juhi</surname>
<given-names>Umme Habiba</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>El-Nashar</surname>
<given-names>Heba A. S.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2577473/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Al Faruq</surname>
<given-names>Abdullah</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2664044/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bhuia</surname>
<given-names>Md. Shimul</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2329940/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sultana</surname>
<given-names>Irin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alam</surname>
<given-names>Syedul</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Abuyousef</surname>
<given-names>Farah</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing//"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Saleh</surname>
<given-names>Na&#x2019;il</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/731229/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>El-Shazly</surname>
<given-names>Mohamed</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/373647/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Islam</surname>
<given-names>Muhammad Torequl</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1999069/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Pharmacy</institution>, <institution>Southern University Bangladesh</institution>, <addr-line>Chattogram</addr-line>, <country>Bangladesh</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Pharmacognosy</institution>, <institution>Faculty of Pharmacy</institution>, <institution>Ain Shams University</institution>, <addr-line>Cairo</addr-line>, <country>Egypt</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Pharmacy</institution>, <institution>Bangabandhu Sheikh Mujibur Rahman Science and Technology University</institution>, <addr-line>Gopalganj</addr-line>, <country>Bangladesh</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Bioluster Research Center</institution>, <addr-line>Dhaka</addr-line>, <country>Bangladesh</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Forest Botany Division</institution>, <institution>Bangladesh Forest Research Institute (BFRI)</institution>, <addr-line>Chattogram</addr-line>, <country>Bangladesh</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Department of Chemistry</institution>, <institution>College of Science</institution>, <institution>United Arab Emirates University</institution>, <addr-line>Al Ain</addr-line>, <country>United Arab Emirates</country>
</aff>
<aff id="aff7">
<sup>7</sup>
<institution>Pharmacy Discipline</institution>, <institution>Khulna University</institution>, <addr-line>Khulna</addr-line>, <country>Bangladesh</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/535884/overview">Elena Lucarini</ext-link>, University of Florence, Italy</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1404782/overview">Rudi Hendra</ext-link>, Riau University, Indonesia</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1060563/overview">Sultan Zahiruddin</ext-link>, University of Mississippi, United States</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Heba A. S. El-Nashar, <email>heba_pharma@pharma.asu.edu.eg</email>; Mohamed El-Shazly, <email>mohamed.elshazly@pharma.asu.edu.eg</email>; Na&#x2019;il Saleh, <email>n.saleh@uaeu.ac.ae</email>; Muhammad Torequl Islam, <email>dmt.islam@bsmrstu.edu.bd</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>04</day>
<month>04</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1366889</elocation-id>
<history>
<date date-type="received">
<day>22</day>
<month>01</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>07</day>
<month>03</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Juhi, El-Nashar, Al Faruq, Bhuia, Sultana, Alam, Abuyousef, Saleh, El-Shazly and Islam.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Juhi, El-Nashar, Al Faruq, Bhuia, Sultana, Alam, Abuyousef, Saleh, El-Shazly and Islam</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>
<bold>Introduction:</bold> <italic>Cheilanthes tenuifolia</italic> is an evergreen ornamental small fern, belonging to the family Pteridaceae, that grows in warm and rocky regions worldwide. Many species of <italic>Cheilanthes</italic> genus are evidently endowed with important phytochemicals and bioactivities. This study aimed to perform a preliminary phytochemical analysis of <italic>Cheilanthes tenuifolia</italic> leaves alongside an evaluation of free radical scavenging, anti-inflammatory, antimicrobial, and clot lysis activities of extract fractions.</p>
<p>
<bold>Materials and methods:</bold> A preliminary phytochemical analysis was done after fractionation of ethanolic extract (ECT) with <italic>n</italic>-hexane (HCT) and chloroform (CCT). Then, 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging, egg albumin and RBC membrane stabilization tests, disc diffusion, and human blood clot lysis assays were performed.</p>
<p>
<bold>Results:</bold> Phytochemical investigations suggested that the plant is rich in alkaloids, glycosides, tannins, and flavonoids. All obtained fractions exhibited concentration-dependent radical scavenging, inhibition of egg protein denaturation and RBC membrane lysis capacities. Except for antifungal tests, ECT exhibited better DPPH radical scavenging, anti-inflammatory, antibacterial, and clot lysis capacities than HCT and CCT fractions. However, all fractions exhibited a mild anti-inflammatory activity.</p>
<p>
<bold>Conclusion:</bold> <italic>C. tenuifolia</italic> might be a good source of antioxidant, anti-microbial, and anti-atherothrombotic agents. Further studies are required to isolate and characterize the active principles liable for each bioactivity, along with possible molecular interactions.</p>
</abstract>
<kwd-group>
<kwd>anti-inflammatory</kwd>
<kwd>
<italic>Cheilanthes tenuifolia</italic>
</kwd>
<kwd>secondary metabolites</kwd>
<kwd>antimicrobial</kwd>
<kwd>membrane stabilization</kwd>
<kwd>anti-atherothrombotic</kwd>
<kwd>radical scavenging</kwd>
</kwd-group>
<contract-sponsor id="cn001">United Arab Emirates University<named-content content-type="fundref-id">10.13039/501100006013</named-content>
</contract-sponsor>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Experimental Pharmacology and Drug Discovery</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Recently, the herbal remedies have been recognized as alternative medical treatments for managing primary healthcare among 80% of the world&#x2019;s populations, especially in low- and medium-income countries (<xref ref-type="bibr" rid="B26">El-Nashar et al., 2021</xref>; <xref ref-type="bibr" rid="B29">El-Shawi et al., 2023</xref>). It is due to the fact that most often synthetic drugs result in many unavoidable adverse events, grow resistance (e.g., antibiotics) and tolerance (e.g., narcotic drugs) due to repeated uses, and thereby reduce safety and efficacy (<xref ref-type="bibr" rid="B36">Ishaq et al., 2022</xref>; <xref ref-type="bibr" rid="B27">El-Nashar et al., 2023b</xref>; <xref ref-type="bibr" rid="B69">Younis et al., 2023</xref>).</p>
<p>The use of pteridophytes (e.g., aka, ferns and fern allies) is ancient (&#x3e;2000&#xa0;years) due to their many beneficial properties. Pteridaceae is recognized as an important family among the pteridophytes. Many species in this family are rich with alkaloids, glycosides, and flavonoids and have promising medicinal features, such as antioxidant, anti-cancer, anti-inflammatory, antimicrobial, antidiabetic, and neurobiological effects (<xref ref-type="bibr" rid="B15">Bhuia et al., 2023a</xref>). Cheilanthes tenuifolia (Burm.f.) Swartz, which belongs to the family Pteridaceae, is a petite, evergreen fern that has the ability to reach a height of 70&#xa0;cm. The delicate lip fern is a species of fern loacal to North America that is considered an ornamental plant (<xref ref-type="bibr" rid="B44">Mahfuz et al., 2019</xref>). It grows properly in open, warm, moist, shady, rocky regions and is often found in small crevices high up on cliffs (<xref ref-type="bibr" rid="B57">Sen and Mukhopadhyay, 2014</xref>; <xref ref-type="bibr" rid="B51">Patel and Reddy, 2018</xref>). It is found in many regions of the world, including Australia, China, Malaysia, Bangladesh, Nepal, Cambodia, Laos, New Zealand, the Philippines, Polynesia, Sri Lanka, Taiwan, Uruguay, Thailand, Vietnam, Tasmania, and India. September to November is considered the growing season for the plants. In India, there are over 30 species of this plant. The fronds are 63&#xa0;cm long and 17&#xa0;cm wide, with a dark red-brown stipe and rachis that are smooth or have sparse hairs consisting of 2&#x2013;13 cells and very few slender scales. The lamina is pentagonal, triangular, or ovate, with 3-4 pinnates at the base and 3 pinnates for most of its length. The larger pinnae are triangular-ovate, the pinnules are lanceolate or ovate, and the ultimate pinnules may have a slightly caudate shape. The margins are either lobed or entire. The upper and lower surfaces of the lamina have very few, short (less than 0.5&#xa0;mm), pointed hairs consisting of 2 or 3 cells, and are occasionally almost hairless. The spores are tetrahedral or rounded-tetrahedral, granulose, and trilete, with a varying degree of reticulate-echinate ornamentation, and have a diameter of 38&#x2013;53&#xa0;&#xb5;m with 32 per sporangium.</p>
<p>Ancient people (prehistoric times) used the rhizome juice of ferns for gastrointestinal disorders (including peptic ulcer), cuts, and wounds. Traditionally, C. tenuifolia leaf juice is mixed with hot water and honey to cure throat pain (<xref ref-type="bibr" rid="B8">Augustin and Thomas, 2015</xref>). Its leaf and stem decoctions are used for healthy hair (<xref ref-type="bibr" rid="B35">Hanum and Hamzah, 1999</xref>). The tribes of Northeast India use its rhizomes and root extracts as general tonics (<xref ref-type="bibr" rid="B14">Benniamin, 2011</xref>; <xref ref-type="bibr" rid="B60">Singh and Upadhyay, 2014</xref>). One study reports that the plant contains important phytochemical groups, like steroids, alkaloids, flavonoids, triterpenoids, phenolic compounds, and tannins (<xref ref-type="bibr" rid="B32">Ghorpade et al., 2015</xref>). To date, two important flavonoids such as quercetin and rutin have been extracted from an ethyl acetate-soluble extract of C. tenuifolia (<xref ref-type="bibr" rid="B38">Jarial et al., 2018</xref>). The plant-derived compound quercetin is a natural aglycone of rutin. It is frequently used in dietary supplements due to its many important and promising bioactivities, including antioxidant, anti-inflammatory, immunomodulatory, antimicrobial, anti-cancer, antidiabetic, antiallergy, antihypertensive, and organ-protective (e.g., brain, heart, liver, kidney, and GIT tract) effects (<xref ref-type="bibr" rid="B4">Ahmed et al., 2022</xref>). A recent investigation proposes that methanolic whole plant extract possesses a significant amount of phenolics and flavonoids and has demonstrated strong antioxidant, cytotoxic, membrane-stabilizing, and thrombolytic activity (<xref ref-type="bibr" rid="B44">Mahfuz et al., 2019</xref>). This study also confirmed that the plant contains stigmasterol. Therefore, there is a lack of adequate scientific studies on this hopeful medicinal plant and there is no detailed information on isolated phytochemicals, anti-inflammatory activity and its underlying mechanisms, antifungal properties, antibacterial effects against huge number of pathogenic bacteria and the molecular mechanisms of each activity.</p>
<p>Knowing the overall facts, this study aimed to do a preliminary phytochemical analysis along with the assessment of the radical scavenging, anti-inflammatory, antimicrobial, and clot lysis capacities of Cheilanthes tenuifolia leaf extracts and this study also evaluated the rectitude of the previous findings of the therapeutic activity of the plant.</p>
</sec>
<sec id="s2">
<title>2 Experimental</title>
<sec id="s2-1">
<title>2.1 Collection, identification, and extraction of plant materials</title>
<p>Fresh leaves were gathered from the Bayazid hill tracts in Chittagong during July and August, which is the period when the plant grows the most. Before mass collection, the plant is identified by a taxonomist at the Bangladesh Forest Research Institute Herbarium (BFRIH), Chittagong [Voucher No. BFRIH-SA (577)]. The decayed leaves, stems, dust, and other parts of the plant were removed with great care. Next, the plant components were rinsed using a continuous flow of tap water and dried in the shade at a temperature lower than 40&#xb0;C. After drying, the materials were crushed into a rough powder and placed in an airtight container that is amber in color. This container was then kept in a cool and dry place until the extraction process began.</p>
<p>A total of 200&#xa0;g of leaf powder was extracted with 1,000&#xa0;mL of absolute ethanol at solvent ratio of 1:5 using a Soxhlet extractor a temperature of 70&#xb0;C for 8&#xa0;h. Then the solvent was dried using a rotary evaporator under diminished pressure. Finally, a gummy ethanolic leaf extract (ECT) was collated. The percentage yield value was determined as follows:<disp-formula id="equ1">
<mml:math id="m1">
<mml:mrow>
<mml:mo>%</mml:mo>
<mml:mtext>Yield</mml:mtext>
<mml:mo>&#x3d;</mml:mo>
<mml:mrow>
<mml:mfenced open="[" close="]" separators="|">
<mml:mrow>
<mml:mtext>Weight&#x2009;of&#x2009;crude&#x2009;extract&#x2009;</mml:mtext>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mtext>gm</mml:mtext>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mo>/</mml:mo>
<mml:mtext>&#x2009;Weight&#x2009;of&#x2009;powder&#x2009;taken&#x2009;</mml:mtext>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mtext>gm</mml:mtext>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>&#xd7;</mml:mo>
<mml:mn>100</mml:mn>
</mml:mrow>
</mml:math>
</disp-formula>
</p>
</sec>
<sec id="s2-2">
<title>2.2 Fractionation of crude ethanolic extract</title>
<p>To perform solvent-solvent partitioning of ECT, 10&#xa0;mL of ECT was dissolved in double-distilled water (DDW), and then fractionated with the aid of a fractionating column with n-hexane (HCT) and subsequently with chloroform (CCT). The fractionation process involved utilizing 50&#xa0;mL of each solvent, for a total of 150&#xa0;mL of n-hexane and chloroform. After vigorous shaking of the mixture, each fraction was allowed to stand, and the solvent layers were then separated and decanted. The remaining extract was considered a fraction of ethanol. The extracts obtained were collected, filtered, and the solvent was evaporated below 50&#xb0;C temperature. As a result of the evaporation process, a sticky concentrate was obtained. The gummy concentrates were weighed and placed in an appropriately labeled and cleaned airtight container and stored at 4&#xb0;C. Percentage yield values for each fraction were determined according to the above-mentioned equation. A general scheme for fractionation has been shown in <xref ref-type="fig" rid="F1">Figure 1</xref>.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Schematic presentation of fractionation of <italic>Cheilanthes tenuifolia</italic> ethanolic leaf extract.</p>
</caption>
<graphic xlink:href="fphar-15-1366889-g001.tif"/>
</fig>
</sec>
<sec id="s2-3">
<title>2.3 Reagents and chemicals</title>
<p>Streptokinase (Altepase<sup>&#xae;</sup>) was purchased from Beacon Pharmaceuticals Ltd., Bangladesh, while ethanol, chloroform, n-hexane, tween 80, acetyl salicylic acid, ascorbic acid, DPPH, nutrient culture media, and other necessary reagents and chemicals were purchased from Merck India.</p>
</sec>
<sec id="s2-4">
<title>2.4 Experimental animals</title>
<p>The study utilized young male Swiss albino mice, which were procured from the animal research branch of the Bangladesh Council of Scientific and Industrial Research (BCSIR) in Chattogram, Bangladesh. These mice had an average weight of 24&#x2013;30&#xa0;g and were maintained in a laboratory setting under standard conditions: a 12-h light/dark cycle, a room temperature of 25&#xb0;C &#xb1; 2&#xb0;C, and a relative humidity of 55%&#x2013;60%. They were provided with a standard diet and had access to water <italic>ad libitum</italic>. To ensure their suitability for the study, the mice were acclimatized to the laboratory environment for 7&#xa0;days and fasted overnight for 12&#xa0;h before the experiments. All ethical considerations were taken into account, and the experimental animals were treated in accordance with the Swiss Academy of Medical Sciences and the Swiss Academy of Sciences Ethical Principles and Guidelines for Scientific Experiments with Animals (1995). Additionally, the Institutional Ethics Committee (SUB/IAEC/12.01) approved all experimental protocols.</p>
</sec>
<sec id="s2-5">
<title>2.5 Acute toxicity analysis and test concentration determination</title>
<p>The test dose for this study of crude extracts was selected by the acute toxicity study following the OECD guidelines using Swiss albino mice. Briefly, the crude ECT was given at doses of 500, 1,000, 2,000, and 3,000&#xa0;mg/kg orally. The animals were then frequently observed for behavioral changes, toxicological symptoms, and death for 2&#xa0;days (<xref ref-type="bibr" rid="B62">Thangjam et al., 2020</xref>).</p>
</sec>
<sec id="s2-6">
<title>2.6 Phytochemical analysis</title>
<p>The phytochemical screening was done according to the method described by (<xref ref-type="bibr" rid="B13">Batool et al., 2020</xref>).</p>
</sec>
<sec id="s2-7">
<title>2.7 Radical scavenging assay</title>
<p>The study assessed the ability of the extracts to scavenge free radicals using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) scavenging assay, as stated by <xref ref-type="bibr" rid="B22">Chowdhury et al. (2010)</xref>, with minor modifications. To prepare the DPPH solution, 0.004% w/v DPPH was solubilized in ethanol, and its absorbance was immediately measured. Next, 1&#xa0;mL of the extract solution at a number of concentrations (20, 40, 60, 80, and 100&#xa0;&#x3bc;g/mL) was added to 2&#xa0;mL of the DPPH solution, mixed thoroughly, and allowed to stand in the dark for 30&#xa0;min to complete the reaction. The same concentrations of ascorbic acid (AA) were utilized as a reference radical scavenger, while ethanol served as a blank. After the reaction time, the absorbance was measured at 517&#xa0;nm using a UV spectrophotometer, and the formula given below was utilized to determine the percentage of inhibition:<disp-formula id="equ2">
<mml:math id="m2">
<mml:mrow>
<mml:mo>%</mml:mo>
<mml:mtext>&#x2009;radical&#x2009;scavenge</mml:mtext>
<mml:mo>&#x3d;</mml:mo>
<mml:mrow>
<mml:mfenced open="[" close="]" separators="|">
<mml:mrow>
<mml:mtext>Absorbance</mml:mtext>
<mml:mo>_</mml:mo>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mtext>Before</mml:mtext>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mtext>&#x2002;</mml:mtext>
<mml:mo>&#x2013;</mml:mo>
<mml:mtext>&#x2009;Absorbance</mml:mtext>
<mml:mo>_</mml:mo>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mtext>After</mml:mtext>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>&#xf7;</mml:mo>
<mml:mtext>Absorbance</mml:mtext>
<mml:mo>_</mml:mo>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mtext>Before</mml:mtext>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mtext>&#x2009;</mml:mtext>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>&#xd7;</mml:mo>
<mml:mn>100</mml:mn>
</mml:mrow>
</mml:math>
</disp-formula>
</p>
<p>The half-minimal inhibitory concentration (IC<sub>50</sub>) was measured utilizing non-linear regression analysis with the aid of Graph Pad Prism software.</p>
</sec>
<sec id="s2-8">
<title>2.8 Anti-inflammatory assay</title>
<sec id="s2-8-1">
<title>2.8.1 Egg albumin test</title>
<p>This test was performed by checking inhibitory effects on egg albumin using the method stated by (<xref ref-type="bibr" rid="B24">Dharmadeva et al., 2018</xref>). Briefly, 0.2&#xa0;mL of egg albumin (from a fresh hen&#x2019;s egg) was mixed with 2.8&#xa0;mL of isosaline (0.9% NaCl, pH 6.4) and 2&#xa0;mL of the test sample or standard drug. Distilled water and acetyl salicylic acid (ASA) were served as control and positive controls, respectively. The sample and standard were tested at 125, 250, and 500&#xa0;&#x3bc;g/mL. The reaction mixtures were incubated at a temperature of 37&#xb0;C &#xb1; 2&#xb0;C for 15&#xa0;min, after which they were heated in a water bath at a temperature of 70&#xb0;C for 5&#xa0;min. Following this, the mixtures were allowed to cool and were filtered through Whatmann filter paper no. 1. Using a colorimeter, the absorbance of every sample was gauged at a 660&#xa0;nm wavelength. The percentage of protein denaturation inhibition was computed utilizing the following equation:<disp-formula id="equ3">
<mml:math id="m3">
<mml:mrow>
<mml:mo>%</mml:mo>
<mml:mtext>inhibition&#x2009;of&#x2009;egg&#x2009;protein</mml:mtext>
<mml:mo>&#x3d;</mml:mo>
<mml:mn>100</mml:mn>
<mml:mo>&#xd7;</mml:mo>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mrow>
<mml:mfenced open="[" close="]" separators="|">
<mml:mrow>
<mml:mtext>Vt</mml:mtext>
<mml:mo>/</mml:mo>
<mml:mtext>Vc</mml:mtext>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:mrow>
</mml:math>
</disp-formula>where, Vt and Vc stand for absorbance of test sample and control, respectively. The IC<sub>50</sub> values were determined as mentioned above.</p>
</sec>
<sec id="s2-8-2">
<title>2.8.2 HRBC membrane stabilization test</title>
<p>This study was conducted using the model developed by (<xref ref-type="bibr" rid="B59">Shinde et al., 1999</xref>) with some minor adjustments. Initially, 5&#xa0;mL of fresh blood was gathered from a healthy donor and mixed with di-potassium salt of EDTA (2.2&#xa0;mg/mL). The blood cells were then accumulated by centrifugation and washed thrice with an isotonic solution (154&#xa0;mM NaCl) in 10&#xa0;mM sodium phosphate buffer (pH 7.4). The resulting cell suspension was re-centrifuged at 3,000&#xa0;<italic>g</italic> for 10&#xa0;min and finally re-suspended in an equal volume of isotonic buffer solution. Next, 0.5&#xa0;mL of the cell suspension was added to a mixture of 5&#xa0;mL of hypotonic solution (50&#xa0;mM NaCl) and 0.5&#xa0;mL of test or standard solution (125, 250, and 500&#xa0;&#x3bc;g/mL) in 10&#xa0;mM sodium phosphate buffered saline (pH 7.4), as specified. The control tube contained only 0.5&#xa0;mL of cell suspension and 5&#xa0;mL of hypotonic solution in the above-mentioned buffer. The reaction mixture was incubated for 10&#xa0;min at room temperature and centrifuged at 3,000&#xa0;<italic>g</italic> for 10&#xa0;min. Finally, the optical density (OD) of the supernatant was quantified at 540&#xa0;nm using a UV-visible spectrophotometer. The percentage inhibition of hemolysis was calculated using the following equation:<disp-formula id="equ4">
<mml:math id="m4">
<mml:mrow>
<mml:mo>%</mml:mo>
<mml:mtext>&#x2009;inhibition&#x2009;of&#x2009;hemolysis</mml:mtext>
<mml:mo>&#x3d;</mml:mo>
<mml:mrow>
<mml:mfenced open="{" close="}" separators="|">
<mml:mrow>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:msub>
<mml:mtext>OD</mml:mtext>
<mml:mtext>control</mml:mtext>
</mml:msub>
<mml:mo>&#x2010;</mml:mo>
<mml:msub>
<mml:mtext>OD</mml:mtext>
<mml:mrow>
<mml:mtext>test</mml:mtext>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mtext>samples</mml:mtext>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>/</mml:mo>
<mml:msub>
<mml:mtext>OD</mml:mtext>
<mml:mtext>control</mml:mtext>
</mml:msub>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>&#xd7;</mml:mo>
<mml:mn>100</mml:mn>
</mml:mrow>
</mml:math>
</disp-formula>
</p>
<p>The IC<sub>50</sub> values were determined as mentioned above.</p>
</sec>
</sec>
<sec id="s2-9">
<title>2.9 Anti-microbial assay</title>
<p>This test was done according to the model stated by (<xref ref-type="bibr" rid="B46">Mbaveng et al., 2008</xref>). The investigation samples were made by solubilizing the extracts of the samples in ethanol (ECT), chloroform (CCT), and n-hexane (HCT). All the samples were tested at 500&#xa0;&#x3bc;g/disc. Ciprofloxacin (CFN) and fluconazole (FCZ) were taken as reference drugs for anti-bacterial and anti-fungal tests, respectively, at 30&#xa0;&#x3bc;g/disc. For this study, we used 4&#xa0;G (&#x2b;) and 7&#xa0;G (&#x2212;) bacteria and 7 fungi (<xref ref-type="table" rid="T1">Table 1</xref>). For the anti-bacterial assay, we used nutrient agar media, while for the anti-fungal assay, we used potato dextrose agar media. After the inoculation of the test pathogen and after allowing the plates to solidify, respective paper discs containing the test sample or standard drug were subsequently impregnated centrally into the agar gel separately with the aid of sterile forceps to achieve complete contact with the previously cultured medium surface. Finally, all the plates were then incubated at 37&#xb0;C for 24&#xa0;h for the anti-bacterial test and at 25&#xb0;C for 72&#xa0;h for the anti-fungal test.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>List of tested pathogens.</p>
</caption>
<table>
<thead>
<tr>
<td colspan="2" align="left">Bacteria</td>
<td rowspan="2" align="left">Fungi</td>
</tr>
<tr>
<td align="left">Gram (&#x2b;ve) species</td>
<td align="left">Gram (&#x2212;ve) species</td>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">
<italic>Bacillus cereus</italic>
</td>
<td align="left">
<italic>Escherichia coli</italic>
</td>
<td align="left">
<italic>Aspergillus niger</italic>
</td>
</tr>
<tr>
<td align="left">
<italic>Bacillus megaterium</italic>
</td>
<td align="left">
<italic>Pseudomonas aeruginosa</italic>
</td>
<td align="left">
<italic>Blastomyces dermatitidis</italic>
</td>
</tr>
<tr>
<td align="left">
<italic>Bacillus subtilis</italic>
</td>
<td align="left">
<italic>Salmonella paratyphi</italic>
</td>
<td align="left">
<italic>Pityrosporum ovale</italic>
</td>
</tr>
<tr>
<td rowspan="4" align="left">
<italic>Staphylococcus aureus</italic>
</td>
<td align="left">
<italic>Salmonella typhi</italic>
</td>
<td align="left">
<italic>Trichophyton</italic> sp</td>
</tr>
<tr>
<td align="left">
<italic>Shigella dysentariae</italic>
</td>
<td align="left">
<italic>Candida albicans</italic>
</td>
</tr>
<tr>
<td align="left">
<italic>Shigeela sonnei</italic>
</td>
<td align="left">
<italic>Microsporum</italic> sp</td>
</tr>
<tr>
<td align="left">
<italic>Vibrio cholera</italic>
</td>
<td align="left">
<italic>Cryptococcus neoformans</italic>
</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2-10">
<title>2.10 Clot lysis assay</title>
<p>This <italic>in vitro</italic> study was done according to the model developed by (<xref ref-type="bibr" rid="B52">Prasad et al., 2006</xref>). In this case, we distributed 0.5&#xa0;mL of fresh blood in pre-weighed microcentrifuge tubes from the non-contraceptive or anti-coagulant receiving humans. After incubating the blood sample at 37&#xb0;C for 45&#xa0;min, the serum was cautiously excluded without disquieting the clot, and tubes were weighed. 100&#xa0;&#x3bc;L of extract at 500&#xa0;&#x3bc;g was added in each tube. 100&#xa0;&#x3bc;L of streptokinase (equiv. 30,000&#xa0;IU) and 100&#xa0;&#x3bc;L of DW were added to the positive control and control marked tubes, respectively. After incubation of the tubes at 37&#xb0;C for 90&#xa0;min, the discharged fluid from each tube was carefully removed, and the tubes were reweighed. The percentage of clot lysis was calculated as follows:<disp-formula id="equ5">
<mml:math id="m5">
<mml:mrow>
<mml:mo>%</mml:mo>
<mml:mtext>&#x2009;Thrombolysis</mml:mtext>
<mml:mo>&#x3d;</mml:mo>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mrow>
<mml:mtext>weight&#x2009;of&#x2009;clot&#x2009;after&#x2009;treatment&#x2009;</mml:mtext>
</mml:mrow>
<mml:mo>/</mml:mo>
<mml:mrow>
<mml:mtext>&#x2009;weight&#x2009;of&#x2009;clot&#x2009;before&#x2009;treatment</mml:mtext>
</mml:mrow>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>&#xd7;</mml:mo>
<mml:mn>100</mml:mn>
</mml:mrow>
</mml:math>
</disp-formula>
</p>
</sec>
<sec id="s2-11">
<title>2.11 Statistical analysis</title>
<p>Values are expressed as mean &#xb1; standard error of mean (SEM). One-way analysis of variance (ANOVA) was followed by Newman Keuls <italic>post host</italic> t-students test using the Graph Pad Prism software (version 6.5) considering <italic>p</italic> &#x3c; 0.05 at 95% confidence of intervals.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>3 Results</title>
<sec id="s3-1">
<title>3.1 Extraction and phytochemical profile</title>
<p>The percentage yield of crude ECT was 5%; that of fractionated ECT, CCT, and HCT was 25, 35, and 25%, respectively. <xref ref-type="table" rid="T2">Table 2</xref> suggests that ECT possesses alkaloids, tannins, glycosides, flavonoids, and saponins, while CCT contains alkaloids, glycosides, steroids, tannins, and flavonoids. HCT contains alkaloids, tannins, glycosides, flavonoids, saponins, and reducing sugars. All the extracts contain alkaloids, glycosides, tannins, and flavonoids. None of these extracts contain gums or amides.</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Phytochemical groups observed in different fractions of <italic>Cheilanthes tenuifolia</italic> leaf extract.</p>
</caption>
<table>
<thead>
<tr>
<td align="left">Fractions</td>
<td align="left">Alkaloids</td>
<td align="left">Glycosides</td>
<td align="left">Steroids</td>
<td align="left">Tannins</td>
<td align="left">Flavonoids</td>
<td align="left">Saponins</td>
<td align="left">Reducing sugar</td>
<td align="left">Gums</td>
<td align="left">Amides</td>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">ECT</td>
<td align="left">&#x2b;&#x2b;&#x2b;</td>
<td align="left">&#x2b;&#x2b;</td>
<td align="left">&#x2012;</td>
<td align="left">&#x2b;&#x2b;</td>
<td align="left">&#x2b;</td>
<td align="left">&#x2b;</td>
<td align="left">&#x2012;</td>
<td align="left">&#x2012;</td>
<td align="left">&#x2012;</td>
</tr>
<tr>
<td align="left">CCT</td>
<td align="left">&#x2b;&#x2b;</td>
<td align="left">&#x2b;&#x2b;</td>
<td align="left">&#x2b;</td>
<td align="left">&#x2b;&#x2b;</td>
<td align="left">&#x2b;</td>
<td align="left">&#x2012;</td>
<td align="left">&#x2012;</td>
<td align="left">&#x2012;</td>
<td align="left">&#x2012;</td>
</tr>
<tr>
<td align="left">HCT</td>
<td align="left">&#x2b;&#x2b;&#x2b;&#x2b;</td>
<td align="left">&#x2b;</td>
<td align="left">&#x2012;</td>
<td align="left">&#x2b;&#x2b;</td>
<td align="left">&#x2b;</td>
<td align="left">&#x2b;</td>
<td align="left">&#x2b;</td>
<td align="left">&#x2012;</td>
<td align="left">&#x2012;</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>&#x2b; &#x3d; Present; &#x2012; &#x3d; Absent; Multiple (&#x2b;) sign indicates the number of test which showed presence of phytochemical group; ECT, ethanolic fraction of <italic>cheilanthes tenuifolia</italic>; CCT, chloroform fraction of <italic>Cheilanthes tenuifolia</italic>; HCT, n-hexane fraction of <italic>Cheilanthes tenuifolia</italic>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3-2">
<title>3.2 LD<sub>50</sub> study and determination of test concentration</title>
<p>The crude ECT up to a 3,000&#xa0;mg/kg oral dose did not cause behavioral changes or toxicological symptoms, or even death, in Swiss mice. Therefore, we used the maximum test concentration of 500&#xa0;&#x3bc;g/mL (equivalent to 500&#xa0;mg/kg) as a test concentration for antimicrobial and clot lysis studies. For radical scavenging, we used the highest concentration, 100&#xa0;&#x3bc;g/mL, while in the anti-inflammatory study, we used 500&#xa0;&#x3bc;g/mL as a high concentration and 125 as a low concentration.</p>
</sec>
<sec id="s3-3">
<title>3.3 Radical scavenging capacity</title>
<p>The control showed negligible DPPH radical scavenging capacity (1.54% &#xb1; 0.11%). All the extracts demonstrated a concentration-dependent radical scavenging capacity in comparison to the control group. The highest inhibition (IC<sub>50</sub> &#x3d; 22.17 &#xb1; 1.90&#xa0;&#x3bc;g/mL) was seen with ECT at all concentrations compared to CCT and HCT. The radical scavenging capacity of all the extracts was significant (<italic>p</italic> &#x3c; 0.05) as compared to the control group. However, the reference drug AA revealed significant (<italic>p</italic> &#x3c; 0.05), strong, and better inhibition at 20&#x2013;100&#xa0;&#x3bc;g/mL than all the test extracts (<xref ref-type="table" rid="T3">Table 3</xref>). The IC<sub>50</sub> values calculated for the CCT, HCT, and AA are 39.79 &#xb1; 1.02, 78.13 &#xb1; 2.08, and 18.77 &#xb1; 1.03&#xa0;&#x3bc;g/mL, respectively. The CI and r<sup>2</sup> value of all the treatment groups are demonstrated in <xref ref-type="table" rid="T3">Table 3</xref>.</p>
<table-wrap id="T3" position="float">
<label>TABLE 3</label>
<caption>
<p>Percentage of scavenging activity of DPPH radicals by the tested extract and controls.</p>
</caption>
<table>
<thead>
<tr style="background-color:#D0CECE">
<td rowspan="2" align="left">Concentration (&#x3bc;g/mL)</td>
<td colspan="4" align="left">Percentage inhibition of DPPH radical</td>
</tr>
<tr style="background-color:#D0CECE">
<td align="left">ECT</td>
<td align="left">CCT</td>
<td align="left">HCT</td>
<td align="left">AA</td>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">20</td>
<td align="left">48.47 &#xb1; 1.78&#x2a;</td>
<td align="left">46.04 &#xb1; 1.31&#x2a;</td>
<td align="left">33.50 &#xb1; 1.93&#x2a;</td>
<td align="left">51.28 &#xb1; 1.11&#x2a;</td>
</tr>
<tr>
<td align="left">40</td>
<td align="left">62.43 &#xb1; 1.58&#x2a;</td>
<td align="left">50.71 &#xb1; 1.23&#x2a;</td>
<td align="left">41.50 &#xb1; 0.96&#x2a;</td>
<td align="left">63.49 &#xb1; 1.13&#x2a;</td>
</tr>
<tr>
<td align="left">60</td>
<td align="left">68.36 &#xb1; 0.93&#x2a;</td>
<td align="left">54.94 &#xb1; 1.07&#x2a;</td>
<td align="left">47.20 &#xb1; 0.57&#x2a;</td>
<td align="left">77.05 &#xb1; 1.67&#x2a;</td>
</tr>
<tr>
<td align="left">80</td>
<td align="left">81.16 &#xb1; 0.13&#x2a;</td>
<td align="left">62.32 &#xb1; 1.05&#x2a;</td>
<td align="left">53.90 &#xb1; 1.11&#x2a;</td>
<td align="left">88.03 &#xb1; 1.02&#x2a;</td>
</tr>
<tr>
<td align="left">100</td>
<td align="left">88.36 &#xb1; 1.23&#x2a;</td>
<td align="left">74.38 &#xb1; 1.01&#x2a;</td>
<td align="left">61.10 &#xb1; 1.09&#x2a;</td>
<td align="left">91.21 &#xb1; 1.08&#x2a;</td>
</tr>
<tr>
<td align="left">IC<sub>50</sub> (&#x3bc;g/mL)</td>
<td align="left">22.17 &#xb1; 1.90</td>
<td align="left">39.79 &#xb1; 1.02</td>
<td align="left">78.13 &#xb1; 2.08</td>
<td align="left">18.77 &#xb1; 1.03</td>
</tr>
<tr>
<td align="left">CI (&#x3bc;g/mL)</td>
<td align="left">15.07&#x2013;27.21</td>
<td align="left">35.37&#x2013;47.13</td>
<td align="left">71.27&#x2013;93.15</td>
<td align="left">13.75&#x2013;25.31</td>
</tr>
<tr>
<td align="left">r<sup>2</sup>
</td>
<td align="left">0.96</td>
<td align="left">0.95</td>
<td align="left">0.87</td>
<td align="left">0.95</td>
</tr>
<tr>
<td align="left">Control</td>
<td colspan="4" align="left">1.54 &#xb1; 0.11</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Values are mean &#xb1; SEM (<italic>n</italic> &#x3d; 3); One-way ANOVA, followed by <italic>t</italic>-student <italic>post hoc</italic> test; &#x2a;<italic>p</italic> &#x3c; 0.05 when compared to the control (vehicle) group; ECT, ethanolic fraction of <italic>Cheilanthes tenuifolia</italic>; CCT, chloroform fraction of <italic>Cheilanthes tenuifolia</italic>; HCT, n-hexane fraction of <italic>Cheilanthes tenuifolia</italic>; AA, ascorbic acid.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3-4">
<title>3.4 Anti-inflammatory activity</title>
<sec id="s3-4-1">
<title>3.4.1 Egg albumin test</title>
<p>The control showed a negligible egg protein denaturation inhibitory effect (1.23% &#xb1; 0.01%). All the extracts showed concentration-dependent protein denaturation inhibitory effects in comparison to the control group. The highest inhibition (49.84% &#xb1; 0.01%) was seen by ECT at 500&#xa0;&#x3bc;g/mL. However, the standard drug ASA exhibited significant (<italic>p</italic> &#x3c; 0.05), strong, and better inhibition at 125&#x2013;500&#xa0;&#x3bc;g/mL than all the test extracts (<xref ref-type="table" rid="T4">Table 4</xref>). The IC<sub>50</sub> values calculated for the ECT, CCT, HCT, and ASA are 511.10 &#xb1; 2.93, 1,001.07 &#xb1; 3.09, 993.03 &#xb1; 3.57, and 122.71 &#xb1; 2.09&#xa0;&#x3bc;g/mL, respectively.</p>
<table-wrap id="T4" position="float">
<label>TABLE 4</label>
<caption>
<p>Percentage inhibition of egg protein denaturation by the tested extract and controls.</p>
</caption>
<table>
<thead>
<tr style="background-color:#D0CECE">
<td rowspan="2" align="left">Parameters (&#x3bc;g/mL)</td>
<td colspan="4" align="center">Percentage inhibition of protein denaturation</td>
</tr>
<tr style="background-color:#D0CECE">
<td align="center">ECT</td>
<td align="center">CCT</td>
<td align="center">HCT</td>
<td align="center">ASA</td>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">125</td>
<td align="left">30.52 &#xb1; 0.01&#x2a;</td>
<td align="left">13.62 &#xb1; 0.01&#x2a;</td>
<td align="left">17.32 &#xb1; 0.01&#x2a;</td>
<td align="left">51.73 &#xb1; 0.01&#x2a;</td>
</tr>
<tr>
<td align="left">250</td>
<td align="left">41.39 &#xb1; 0.01&#x2a;</td>
<td align="left">18.78 &#xb1; 0.01&#x2a;</td>
<td align="left">20.26 &#xb1; 0.01&#x2a;</td>
<td align="left">60.13 &#xb1; 0.01&#x2a;</td>
</tr>
<tr>
<td align="left">500</td>
<td align="left">49.84 &#xb1; 0.01&#x2a;</td>
<td align="left">26.13 &#xb1; 0.01&#x2a;</td>
<td align="left">28.10 &#xb1; 0.01&#x2a;</td>
<td align="left">71.52 &#xb1; 0.01&#x2a;</td>
</tr>
<tr>
<td align="left">IC<sub>50</sub> (&#x3bc;g/mL)</td>
<td align="left">511.10 &#xb1; 2.93</td>
<td align="left">1,001.07 &#xb1; 3.09</td>
<td align="left">993.03 &#xb1; 3.57</td>
<td align="left">122.71 &#xb1; 2.09</td>
</tr>
<tr>
<td align="left">CI (&#x3bc;g/mL)</td>
<td align="left">477.17&#x2013;527.57</td>
<td align="left">945.31&#x2013;1,047.73</td>
<td align="left">951.19&#x2013;1,023.01</td>
<td align="left">113.09&#x2013;147.18</td>
</tr>
<tr>
<td align="left">r<sup>2</sup>
</td>
<td align="left">0.87</td>
<td align="left">0.88</td>
<td align="left">0.89</td>
<td align="left">0.91</td>
</tr>
<tr>
<td align="left">Control</td>
<td colspan="4" align="left">1.23 &#xb1; 0.01</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Values are mean &#xb1; SEM (n &#x3d; 3); One-way ANOVA, followed by <italic>t</italic>-student <italic>post hoc</italic> test; &#x2a;<italic>p</italic> &#x3c; 0.05 when compared to the control (vehicle) group; ECT: ethanolic fraction of <italic>Cheilanthes tenuifolia</italic>; CCT, chloroform fraction of <italic>Cheilanthes tenuifolia</italic>; HCT, n-hexane fraction of <italic>Cheilanthes tenuifolia</italic>; ASA, acetyl salicylic acid.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3-4-2">
<title>3.4.2 HRBC membrane stabilization test</title>
<p>The control showed negligible membrane lysing inhibitory effect (1.73% &#xb1; 0.01%) on HRBCs. All the extracts showed concentration-dependent membrane lysis inhibitory effects in comparison to the control group. The highest inhibition (45.85% &#xb1; 0.01%) was seen by ECT at 500&#xa0;&#x3bc;g/mL. However, the standard drug ASA exhibited significant (<italic>p</italic> &#x3c; 0.05), strong, and better inhibition at 250 and 500&#xa0;&#x3bc;g/mL than all the test extracts (<xref ref-type="table" rid="T5">Table 5</xref>). The IC<sub>50</sub> values calculated for the ECT, CCT, HCT, and ASA are 587.19 &#xb1; 1.33, 2021.03 &#xb1; 3.79, 1,524.09 &#xb1; 2.96, and 209.79 &#xb1; 2.13&#xa0;&#x3bc;g/mL, respectively.</p>
<table-wrap id="T5" position="float">
<label>TABLE 5</label>
<caption>
<p>Percentage inhibition of membrane lysis by the tested extract and controls.</p>
</caption>
<table>
<thead>
<tr style="background-color:#D0CECE">
<td rowspan="2" align="left">Parameters (&#x3bc;g/mL)</td>
<td colspan="4" align="center">Percentage inhibition of RBC membrane lysis</td>
</tr>
<tr style="background-color:#D0CECE">
<td align="center">ECT</td>
<td align="center">CCT</td>
<td align="center">HCT</td>
<td align="center">ASA</td>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">125</td>
<td align="left">11.33 &#xb1; 0.01&#x2a;</td>
<td align="left">3.58 &#xb1; 0.01&#x2a;</td>
<td align="left">3.92 &#xb1; 0.01&#x2a;</td>
<td align="left">43.42 &#xb1; 0.01&#x2a;</td>
</tr>
<tr>
<td align="left">250</td>
<td align="left">23.51 &#xb1; 0.01&#x2a;</td>
<td align="left">7.56 &#xb1; 0.01&#x2a;</td>
<td align="left">10.92 &#xb1; 0.01&#x2a;</td>
<td align="left">58.61 &#xb1; 0.01&#x2a;</td>
</tr>
<tr>
<td align="left">500</td>
<td align="left">45.85 &#xb1; 0.01&#x2a;</td>
<td align="left">11.61 &#xb1; 0.01&#x2a;</td>
<td align="left">21.14 &#xb1; 0.01&#x2a;</td>
<td align="left">70.23 &#xb1; 0.01&#x2a;</td>
</tr>
<tr>
<td align="left">IC<sub>50</sub> (&#x3bc;g/mL)</td>
<td align="left">587.19 &#xb1; 1.33</td>
<td align="left">2021.03 &#xb1; 3.79</td>
<td align="left">1,524.09 &#xb1; 2.96</td>
<td align="left">209.79 &#xb1; 2.13</td>
</tr>
<tr>
<td align="left">CI (&#x3bc;g/mL)</td>
<td align="left">567.13&#x2013;621.07</td>
<td align="left">1843.33&#x2013;2,103.03</td>
<td align="left">1,453.11&#x2013;1,603.10</td>
<td align="left">193.39&#x2013;217.13</td>
</tr>
<tr>
<td align="left">r<sup>2</sup>
</td>
<td align="left">0.90</td>
<td align="left">0.86</td>
<td align="left">0.87</td>
<td align="left">0.89</td>
</tr>
<tr>
<td align="left">Control</td>
<td colspan="4" align="left">1.73 &#xb1; 0.01</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Values are mean &#xb1; SEM (<italic>n</italic> &#x3d; 3); One-way ANOVA, followed by <italic>t</italic>-student <italic>post hoc</italic> test; &#x2a;<italic>p</italic> &#x3c; 0.05 when compared to the control (vehicle) group; ECT, ethanolic fraction of <italic>Cheilanthes tenuifolia</italic>; CCT, chloroform fraction of <italic>Cheilanthes tenuifolia</italic>; HCT, n-hexane fraction of <italic>Cheilanthes tenuifolia</italic>; ASA, acetyl salicylic acid.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="s3-5">
<title>3.5 Anti-bacterial sensitivity</title>
<p>
<xref ref-type="table" rid="T6">Table 6</xref> suggests that ECT (ZI range: 8.70 &#xb1; 1.00 to 15.00 &#xb1; 1.00&#xa0;mm), CCT (ZI range: 8.30 &#xb1; 0.60 to 15.30 &#xb1; 1.20&#xa0;mm), and HCT (ZI range: 8.30 &#xb1; 1.50 to 12.70 &#xb1; 0.60&#xa0;mm) showed sensitivity towards all the test bacteria except <italic>V. cholerae</italic> at 500&#xa0;&#xb5;g/disc. However, the extracts were more active against the Gram (&#x2b;) species. The standard drug CFN inhibited the growth of all the investigated bacteria within the range of ZI 11.30 &#xb1; 1.00 to 16.00 &#xb1; 1.00&#xa0;mm at 30&#xa0;&#xb5;g/disc.</p>
<table-wrap id="T6" position="float">
<label>TABLE 6</label>
<caption>
<p>Zone of inhibition observed against the test bacteria in the test and standard group.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th rowspan="2" align="left">Bacteria</th>
<th colspan="4" align="left">Zone of inhibition (mm)</th>
</tr>
<tr>
<th align="left">ECT</th>
<th align="left">CCT</th>
<th align="left">HCT</th>
<th align="left">CFN</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td colspan="5" align="left">Gram positive species</td>
</tr>
<tr>
<td align="left">
<italic>B. cereus</italic>
</td>
<td align="left">15.00 &#xb1; 1.00</td>
<td align="left">15.30 &#xb1; 1.20</td>
<td align="left">9.00 &#xb1; 2.00</td>
<td align="left">16.00 &#xb1; 1.00</td>
</tr>
<tr>
<td align="left">
<italic>B. megateriuum</italic>
</td>
<td align="left">11.00 &#xb1; 1.00</td>
<td align="left">12.50 &#xb1; 1.80</td>
<td align="left">9.70 &#xb1; 1.50</td>
<td align="left">14.70 &#xb1; 1.50</td>
</tr>
<tr>
<td align="left">
<italic>B. subtilis</italic>
</td>
<td align="left">12.00 &#xb1; 1.00</td>
<td align="left">13.00 &#xb1; 1.00</td>
<td align="left">8.30 &#xb1; 1.50</td>
<td align="left">16.00 &#xb1; 1.00</td>
</tr>
<tr>
<td align="left">
<italic>S. aureus</italic>
</td>
<td align="left">13.00 &#xb1; 0.00</td>
<td align="left">13.30 &#xb1; 0.60</td>
<td align="left">12.70 &#xb1; 0.60</td>
<td align="left">16.70 &#xb1; 1.50</td>
</tr>
<tr>
<td colspan="5" align="left">Gram negative species</td>
</tr>
<tr>
<td align="left">
<italic>E. coli</italic>
</td>
<td align="left">8.70 &#xb1; 1.20</td>
<td align="left">8.30 &#xb1; 0.60</td>
<td align="left">9.30 &#xb1; 2.30</td>
<td align="left">15.50 &#xb1; 0.50</td>
</tr>
<tr>
<td align="left">
<italic>Sh. dysenteriae</italic>
</td>
<td align="left">8.70 &#xb1; 1.00</td>
<td align="left">8.50 &#xb1; 0.50</td>
<td align="left">8.70 &#xb1; 1.20</td>
<td align="left">14.70 &#xb1; 1.00</td>
</tr>
<tr>
<td align="left">
<italic>Sh. sonnei</italic>
</td>
<td align="left">10.00 &#xb1; 1.00</td>
<td align="left">9.30 &#xb1; 0.58</td>
<td align="left">Ni</td>
<td align="left">13.80 &#xb1; 0.30</td>
</tr>
<tr>
<td align="left">
<italic>Sal. paratyphi</italic>
</td>
<td align="left">11.00 &#xb1; 1.00</td>
<td align="left">Ni</td>
<td align="left">Ni</td>
<td align="left">12.50 &#xb1; 1.50</td>
</tr>
<tr>
<td align="left">
<italic>Sal. typhi</italic>
</td>
<td align="left">8.70 &#xb1; 0.60</td>
<td align="left">Ni</td>
<td align="left">Ni</td>
<td align="left">13.00 &#xb1; 0.50</td>
</tr>
<tr>
<td align="left">
<italic>P. aeruginosa</italic>
</td>
<td align="left">12.00 &#xb1; 1.00</td>
<td align="left">10.00 &#xb1; 1.00</td>
<td align="left">12.00 &#xb1; 1.00</td>
<td align="left">11.30 &#xb1; 1.00</td>
</tr>
<tr>
<td align="left">
<italic>V. cholerae</italic>
</td>
<td align="left">Ni</td>
<td align="left">Ni</td>
<td align="left">Ni</td>
<td align="left">13.80 &#xb1; 0.30</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Values are mean &#xb1; SEM (<italic>n</italic> &#x3d; 3); ZI, Zone of inhibition (mm); ZI, below 8&#xa0;mm were considered as less sensitive and were discarded; Ni, No inhibition.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3-6">
<title>3.6 Anti-fungal sensitivity</title>
<p>
<xref ref-type="table" rid="T7">Table 7</xref> suggests that ECT (ZI range: 9.00 &#xb1; 0.20 to 11.00 &#xb1; 0.50&#xa0;mm), CCT (ZI range: 8.70 &#xb1; 0.20 to 12.70 &#xb1; 0.50&#xa0;mm), and HCT (ZI range: 10.00 &#xb1; 0.50 to 11.70 &#xb1; 0.20&#xa0;mm) showed sensitivity towards <italic>A. niger</italic>, <italic>B. dermatitidis</italic>, <italic>C. albicans</italic> and <italic>P. ovale</italic>. However, all the extracts remain insensitive at 500&#xa0;&#xb5;g/disc against the other test fungi. The standard drug FCZ inhibited the growth of all the test fungi within the range of ZI 11.00 &#xb1; 0.40 to 15.30 &#xb1; 0.50&#xa0;mm at 30&#xa0;&#xb5;g/disc.</p>
<table-wrap id="T7" position="float">
<label>TABLE 7</label>
<caption>
<p>Zone of inhibition observed against the test fungi in the test and standard group.</p>
</caption>
<table>
<thead>
<tr style="background-color:#D0CECE">
<td rowspan="2" align="left">Fungi</td>
<td colspan="4" align="center">Zone of inhibition (mm)</td>
</tr>
<tr style="background-color:#D0CECE">
<td align="left">ECT</td>
<td align="left">CCT</td>
<td align="left">HCT</td>
<td align="left">FCZ</td>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">
<italic>A. niger</italic>
</td>
<td align="left">9.00 &#xb1; 0.20</td>
<td align="left">10.00 &#xb1; 0.30</td>
<td align="left">10.30 &#xb1; 0.20</td>
<td align="left">14.30 &#xb1; 0.30</td>
</tr>
<tr>
<td align="left">
<italic>B. dermatitidis</italic>
</td>
<td align="left">11.00 &#xb1; 0.50</td>
<td align="left">11.70 &#xb1; 0.20</td>
<td align="left">11.00 &#xb1; 0.30</td>
<td align="left">12.30 &#xb1; 0.30</td>
</tr>
<tr>
<td align="left">
<italic>C. albicans</italic>
</td>
<td align="left">10.00 &#xb1; 0.42</td>
<td align="left">12.70 &#xb1; 0.50</td>
<td align="left">11.70 &#xb1; 0.20</td>
<td align="left">15.30 &#xb1; 0.50</td>
</tr>
<tr>
<td align="left">
<italic>P. ovale</italic>
</td>
<td align="left">9.00 &#xb1; 0.23</td>
<td align="left">8.70 &#xb1; 0.20</td>
<td align="left">10.00 &#xb1; 0.50</td>
<td align="left">13.30 &#xb1; 0.30</td>
</tr>
<tr>
<td align="left">
<italic>Tricho.</italic> sp</td>
<td align="left">Ni</td>
<td align="left">Ni</td>
<td align="left">Ni</td>
<td align="left">11.00 &#xb1; 0.40</td>
</tr>
<tr>
<td align="left">
<italic>Micro.</italic> sp</td>
<td align="left">Ni</td>
<td align="left">Ni</td>
<td align="left">Ni</td>
<td align="left">15.30 &#xb1; 0.50</td>
</tr>
<tr>
<td align="left">
<italic>C. neoformans</italic>
</td>
<td align="left">Ni</td>
<td align="left">Ni</td>
<td align="left">Ni</td>
<td align="left">14.30 &#xb1; 0.30</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Values are mean &#xb1; SEM (<italic>n</italic> &#x3d; 3); ZI: Zone of inhibition (mm); ZI, below 8&#xa0;mm were considered as less sensitive and were discarded; Ni, No inhibition.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3-7">
<title>3.7 Clot lysis activity</title>
<p>All the selected extracts at 500&#xa0;&#xb5;g/100&#xa0;&#xb5;L exhibited significant (<italic>p</italic> &#x3c; 0.05) clot lysis capacity as compared to the control (vehicle) group. Among the extracts, ECT exhibited better clot lysis capacity (61.71 &#xb1; 0.03) than the CCT and HCT. However, the standard streptokinase (equiv. 30,000&#xa0;IU)/100&#xa0;&#xb5;L exhibited more clot lysis capacity than the test samples (<xref ref-type="table" rid="T8">Table 8</xref>).</p>
<table-wrap id="T8" position="float">
<label>TABLE 8</label>
<caption>
<p>Clot lysing capacity of the test and controls.</p>
</caption>
<table>
<thead>
<tr style="background-color:#D0CECE">
<td colspan="2" align="left">Treatments (100&#xa0;&#xb5;L)</td>
<td align="left">Clot lysis (%)</td>
</tr>
</thead>
<tbody valign="top">
<tr>
<td colspan="2" align="left">Distilled water (control)</td>
<td align="left">3.72 &#xb1; 0.01</td>
</tr>
<tr>
<td colspan="2" align="left">Streptokinase (standard) (30,000&#xa0;IU)</td>
<td align="left">85.56 &#xb1; 0.03&#x2a;</td>
</tr>
<tr>
<td rowspan="3" align="left">Conc. 500&#xa0;&#x3bc;g</td>
<td align="left">ECT</td>
<td align="left">61.71 &#xb1; 0.03&#x2a;</td>
</tr>
<tr>
<td align="left">CCT</td>
<td align="left">37.80 &#xb1; 0.02&#x2a;</td>
</tr>
<tr>
<td align="left">HCT</td>
<td align="left">15.19 &#xb1; 0.04&#x2a;</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Values are mean &#xb1; SEM (<italic>n</italic> &#x3d; 5); One-way ANOVA, followed by <italic>t</italic>-student <italic>post hoc</italic> test; &#x2a;<italic>p</italic> &#x3c; 0.05 when compared to the control (vehicle) group; ECT: ethanolic fraction of <italic>Cheilanthes tenuifolia</italic>; CCT, chloroform fraction of <italic>Cheilanthes tenuifolia</italic>; HCT, n-hexane fraction of <italic>Cheilanthes tenuifolia</italic>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>4 Discussion</title>
<p>Among the natural products, plants are common sources of traditional healing agents worldwide, especially in the poor and less developed countries (<xref ref-type="bibr" rid="B6">Ashmawy et al., 2023</xref>; <xref ref-type="bibr" rid="B47">Mia et al., 2023</xref>). On the other hand, people in developed countries are now conscious of the adverse events of modern drugs, thus there is a developing enthusiasm for research into and utilization of plant-mediated products or preparations (<xref ref-type="bibr" rid="B1">Abdelazim et al., 2024</xref>; <xref ref-type="bibr" rid="B58">Shill et al., 2024</xref>). Plant extracts contain numerous groups and components, including alkaloids, glycosides, phenolics and flavonoids, vitamins, and minerals (<xref ref-type="bibr" rid="B34">Gunathilake et al., 2018</xref>). Certain groups of compounds have diverse bioactivities, for example, phenolics and flavonoids have promising antioxidant and anti-inflammatory activities (<xref ref-type="bibr" rid="B64">Tlili et al., 2013</xref>) and play many important roles in biological systems such as anti-inflammatory (<xref ref-type="bibr" rid="B33">Ginwala et al., 2019</xref>), antibacterial, anti-cancer (<xref ref-type="bibr" rid="B39">Khalil et al., 2020</xref>), and anti-atherosclerotic effect (<xref ref-type="bibr" rid="B56">Salvamani et al., 2014</xref>). A certain study reported that certain organic polar solvents, such as ethanol and methanol, are the best solvents for the extraction of phenolics from natural sources (<xref ref-type="bibr" rid="B10">Ballard et al., 2009</xref>). Alkaloids, on the contrary, play vital roles in plants and humans. It is because these are considered defensive compounds. Alkaloids also regulate the growth of plants (<xref ref-type="bibr" rid="B21">Chik et al., 2013</xref>). Furthermore, glycosides have many significant therapeutic potentials, including antifungal (<xref ref-type="bibr" rid="B40">Khan et al., 2017</xref>) and anticancer (<xref ref-type="bibr" rid="B41">Khan et al., 2019</xref>) activities. Current drug development methodologies and modern medicine do not use complete plant extracts and instead rely on specific compounds. Taking the whole plant or extracts without isolating components as practiced in traditional medicine has a stronger therapeutic impact than specific substances (<xref ref-type="bibr" rid="B67">Wen et al., 2005</xref>; <xref ref-type="bibr" rid="B63">Thomford et al., 2018</xref>). Therefore, the isolated chemical constituents are important for developing novel drugs.</p>
<p>The plant is evidently composed of steroids, alkaloids, flavonoids, triterpenoids, phenolic compounds, and tannins (<xref ref-type="bibr" rid="B32">Ghorpade et al., 2015</xref>). Another study reports that the plant is rich in phenolics and flavonoids. It contains quercetin, rutin, and stigmasterol (<xref ref-type="bibr" rid="B44">Mahfuz et al., 2019</xref>). Our study also confirmed that the plant contains stigmasterol. In this study, we have seen that ethanolic leaf fractions of C. tenuifolia contain flavonoids. Additionally, we have also found that the plant leaf contains alkaloids, steroids, saponins, glycosides, and reducing sugars. Thus, the compounds of these phytochemical groups may be linked to the observed bioactivities. However, safety pharmacology is critical throughout the drug discovery and development process. Prior to first-in-human investigations, safety pharmacology assays, tests, and models anticipate the clinical risk profile of a possible new medicine (<xref ref-type="bibr" rid="B50">Morimoto et al., 2015</xref>). According to the findings of our study the crude ECT up to a 3,000&#xa0;mg/kg oral dose did not show any behavioral changes or toxicological symptoms, or even death, in Swiss mice. Previous study on the plant extract showed that the LC<sub>50</sub> values of the chloroform, n-hexane, methanol soluble and ethyl acetate extracts were 34.493&#xa0;&#x3bc;g/mL, 205.984&#xa0;&#x3bc;g/mL, 751.169&#xa0;&#x3bc;g/mL and 66.235&#xa0;&#x3bc;g/mL respectively on shrimp nauplii (<xref ref-type="bibr" rid="B44">Mahfuz et al., 2019</xref>).</p>
<p>Oxidative stress from various sources due to an overabundance of reactive species production (e.g., ROS, RNS) is considered a precursor of diseases and disorders in humans. This can lead to neurological and cardiovascular diseases, cancer, diabetes, etc. (<xref ref-type="bibr" rid="B53">Rekatsina et al., 2020</xref>; <xref ref-type="bibr" rid="B30">Forman and Zhang, 2021</xref>). Antioxidants are the substances that act against oxidative stress. External antioxidants are required once our body&#x2019;s defensive mechanisms, including physiological antioxidants, fail to manage an overabundance of free radicals. Plant-based natural antioxidants play significant roles in managing this situation (<xref ref-type="bibr" rid="B37">Jamshidi-Kia et al., 2020</xref>). It is due to their being readily available, economic, and biocompatible. Moreover, we can readily access these compounds through our daily diets (<xref ref-type="bibr" rid="B43">Landete, 2013</xref>). In a recent experiment, <xref ref-type="bibr" rid="B44">Mahfuz et al. (2019)</xref> demonstrated that methanolic whole plant extract exhibited strong (IC<sub>50</sub> &#x3d; 9.926&#xa0;&#x3bc;g/mL) DPPH free radical scavenging capacity. Another investigation of the plant&#x2019;s methanolic extract found that the two flavonoids (rutin and quercetin) present in the extract showed considerable <italic>in vitro</italic> anti-oxidant activity; in this regard, the DPPH scavenging capability of quercetin (86.1%) was higher than that of rutin (73.2%) (<xref ref-type="bibr" rid="B38">Jarial et al., 2018</xref>; <xref ref-type="bibr" rid="B23">Daryono and Rhomawati, 2020</xref>; <xref ref-type="bibr" rid="B23">Daryono and Rhomawati, 2020</xref>). Another bioactive triterpenoid isolated from the n-hexane extract of the plant also has potent antioxidant capacity such as stigmasterol (<xref ref-type="bibr" rid="B44">Mahfuz et al., 2019</xref>), which significantly reduced the ROS generation in different <italic>in vitro</italic> investigation (<xref ref-type="bibr" rid="B3">Agatonovic-Kustrin et al., 2018</xref>; <xref ref-type="bibr" rid="B9">Bakrim et al., 2022</xref>).</p>
<p>In this investigation, we have seen that all the fractions of C. tenuifolia revealed significant DPPH free radical scavenging capacity in a concentration-dependent manner, with the IC<sub>50</sub> values estimated for the ECT, HCT, and CCT within the range of 22.17 &#xb1; 1.90 to 78.13 &#xb1; 2.08&#xa0;&#x3bc;g/mL, respectively. ECT exhibited a better DPPH radical scavenging effect than the other two fractions. It is because of the large amount of phenolics and flavonoids in this fraction such as rutin and quercetin as well as terpenoids including stigmasterol (<xref ref-type="bibr" rid="B38">Jarial et al., 2018</xref>; <xref ref-type="bibr" rid="B44">Mahfuz et al., 2019</xref>). The promising DPPH radical scavenging effect of other species of Cheilanthes such as C. anceps also reported by (<xref ref-type="bibr" rid="B22">Chowdhary et al., 2010</xref>).</p>
<p>Oxidative stress can provoke inflammatory cascades. Thus, antioxidants have protective effects in a biological system. Certain antioxidants, such as polyphenols, have an anti-ageing effect (<xref ref-type="bibr" rid="B49">Moliner et al., 2020</xref>), and these can prevent or delay many disease conditions, including neurological diseases and disorders, cardiovascular diseases, diabetes, and so on (<xref ref-type="bibr" rid="B54">Rodr&#xed;guez-Yoldi, 2021</xref>; <xref ref-type="bibr" rid="B16">Bhuia et al., 2023b</xref>). A study performed by Mahfuz and his coworkers in 2019 suggests that the methanol, n-hexane, ethyl acetate, and chloroform fractions of C. tenuifolia showed significant membrane stabilizing capacity in the HRBC assay, where the percent inhibition of hemolysis was determined within the range of 2.97 and 73.97 (<xref ref-type="bibr" rid="B44">Mahfuz et al., 2019</xref>). The n-hexane fraction showed the highest percent inhibition against hypnotic solution-induced hemolysis (73.97%), while the ethyl acetate fraction showed the highest percent inhibition of heat-induced hemolysis (67.27%). Our study demonstrated that the organic fractions of C. tenuifolia, especially its ECT, exhibited significant egg protein and HRBC protection capabilities. Another study by Akbor et al. (2023) also stated that methanolic extract of the plant has a notable membrane lysing inhibitory activity (1.42% &#xb1; 0.02%) on HRBCs (Akbor et al., 2023). One report suggested that the species C. farinose is traditionally used to manage inflammation (<xref ref-type="bibr" rid="B68">Yonathan et al., 2006</xref>). Thus, our present findings are in agreement with the traditional values and scientific reports observed in the databases. According to the findings of different studies the bioactive substances (rutin, and quercetin) of the plant has potent anti-inflammatory activity and liable for diminishing different inflammatory markers such as cytokines (<xref ref-type="bibr" rid="B2">Abd Nikfarjam et al., 2017</xref>; <xref ref-type="bibr" rid="B17">Bhuia et al., 2023c</xref>).</p>
<p>Infectious diseases due to microbial attacks (e.g., bacteria, fungi, viruses, and parasites) in humans are a common consequence in the world. Among the wide variety of natural products, plants are considered major sources of antimicrobial agents (<xref ref-type="bibr" rid="B65">Touati et al., 2018</xref>). The species of the Pteridaceae family are known for their diverse bioactivities, including antioxidant, anti-inflammatory, antimicrobial, anti-cancer, antidiabetic, and neurobiological properties (<xref ref-type="bibr" rid="B12">Baskaran et al., 2018</xref>). To date, a number of bioactive compounds have been introduced from the Cheilanthes genus, for example, glycosides of apigenin, chrysoeriol, luteolin, kaempferol, and quercetin from C. concolor, <italic>C. flexuosa</italic> and C. goyazensis (<xref ref-type="bibr" rid="B55">Salatino and Prado, 1998</xref>). In this study, we have seen that all the organic fractions of C. tenuifolia acted against both gram (&#x2b;) and gram (&#x2212;) species as well as many pathogenic fungi, suggesting its broad-spectrum anti-microbial effects. Conventional antimicrobial agents have some potential adverse effects, for example, allergic reactions and enhanced resistance (<xref ref-type="bibr" rid="B48">Mohsen et al., 2020</xref>). For example, chloramphenicol is widely used in meningitis, but it increases the risk of aplastic anemia. Another example is sulfonamides, which were considered &#x201c;wonder drugs,&#x201d; but these are evidently contributing to severe skin reactions (<xref ref-type="bibr" rid="B42">King et al., 2018</xref>). Therefore, it is crucial to inhibit microbial pathogenesis using appropriate and safe antimicrobials (<xref ref-type="bibr" rid="B31">French, 2005</xref>). Previous study by <xref ref-type="bibr" rid="B38">Jarial et al. (2018)</xref> also manifested the antimicrobial properties of the plant and the study also revealed that isolated flavonoids such as quercetin and rutin from C. tenuifolia showed inhibitory effects against <italic>Staphylococcus aureus</italic> and <italic>Enterobacter</italic> sp. with MIC values of (2.25 and 0.45&#xa0;&#x3bc;g/mL), respectively (<xref ref-type="bibr" rid="B38">Jarial et al., 2018</xref>).</p>
<p>Atherothrombosis is one of the major causes of morbidity and mortality in the world. Chronic pathology is responsible for vascular remodeling through various pathways, including oxidative stress (<xref ref-type="bibr" rid="B45">Martin-Ventura et al., 2017</xref>). ROS and RNS play important pathophysiological roles in vascular diseases, such as atherothrombosis (<xref ref-type="bibr" rid="B20">Chen et al., 2018</xref>). It is also evident that microorganism-mediated infections result in the production of potentially reactive molecules in our body through oxygen metabolism (<xref ref-type="bibr" rid="B18">Brown et al., 2014</xref>), which is responsible for many pathological conditions, including inflammation, atherosclerosis, carcinogenesis, and so on (<xref ref-type="bibr" rid="B5">Aruoma, 1998</xref>). The methanolic whole plant extract is evidently able to exert significant clot lysis capacity at 100&#xa0;&#xb5;g/tube (<xref ref-type="bibr" rid="B44">Mahfuz et al., 2019</xref>). The authors demonstrated that the ethyl acetate, n-hexane, methanol, and chloroform fractions exhibited 31.59, 12.10, 17.01, and 41.26% clot lysis capacities, respectively. Another study by Akbor et al. (2023) also reported that the methanolic extract of the plant hindered hemolysis in a concentration-dependent manner and inhibited 78.93% &#xb1; 0.01% hemolysis (IC<sub>50</sub> &#x3d; 46 &#xb1; 2.11&#xa0;&#x3bc;g/mL) at the higher concentration (160&#xa0;&#x3bc;g/mL) (Akbor et al., 2023). Findings of our study suggest that ECT, CCT, and HCT showed clot lysis capacities of 61.71 &#xb1; 0.03, 37.80 &#xb1; 0.02, and 15.19% &#xb1; 0.04% at 500&#xa0;&#xb5;g/tube. ECT showed better clot lysis capacity than the other two fractions. Due to the presence of different phytochemicals such as alkaloids, flavonoids, and steroids (<xref ref-type="bibr" rid="B66">Uddin et al., 2019</xref>; <xref ref-type="bibr" rid="B61">Tabassum et al., 2022</xref>), the bioactive phytoconstituents of the plant such as rutin, quercetin, and stigmasterol also have remarkable hemolytic activity (<xref ref-type="bibr" rid="B70">Zaragoza et al., 2021</xref>; <xref ref-type="bibr" rid="B11">Bari et al., 2022</xref>; <xref ref-type="bibr" rid="B19">Chen et al., 2022</xref>). We suppose that the observed clot lysis capacity, especially by the ECT, might be linked to the existence of phytochemical groups such as alkaloids, glycosides, and flavonoids and bioactivity such as radical scavenging, anti-inflammatory, and anti-microbial activities. Natural products and their structural counterparts have historically made significant contributions to pharmacology, particularly in cancer and infectious disorders (<xref ref-type="bibr" rid="B28">El-Nashar et al., 2024</xref>). Nonetheless, natural products pose hurdles for drug development, such as technical barriers to screening, isolation, characterization, and optimization, which have contributed to a drop in their pursuit by the pharmaceutical industry since the 1990s (<xref ref-type="bibr" rid="B7">Atanasov et al., 2021</xref>; <xref ref-type="bibr" rid="B25">El-Nashar et al., 2023a</xref>).</p>
</sec>
<sec id="s5">
<title>5 Conclusion and future prospects</title>
<p>As a conclusion, the organic fractions of C. tenuifolia leaf extract remain rich in many valuable phytochemical groups, including alkaloids, tannins, glycosides, flavonoids, and saponins. All the fractions exhibited concentration-dependent and significant radical scavenging, anti-inflammatory, and anti-microbial effects against different gram (&#x2b;) and gram (&#x2212;) bacteria, as well as a number of pathogenic fungi, and clot lysis capacities. ECT exhibited better anti-radical (IC<sub>50</sub> &#x3d; 22.17 &#xb1; 1.90), anti-inflammatory, anti-bacterial, and clot-lysis capacity than the CCT and HCT. We suppose that all the activities, because of the presence of alkaloids, glycosides, and flavonoids within the organic fractions of C. tenuifolia leaf extract and the bioactive compound rutin, quercetin and stigmasterol play an important role in exerting therapeutic activities against oxidative stress and inflammation related diseases and disorders, pathogenic infections and a good source of thrombolytic agents. However, additional research is deemed necessary to conduct the isolation, identification, and clarification of the underlying molecular mechanisms responsible for each individual bioactivity as well as clinical investigation of the plant&#x2019;s extract and exploited phytochemicals which would be useful in producing plant-based pharmaceuticals to treat numerous complicated human diseases.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s6">
<title>Data availability statement</title>
<p>The raw data supporting the conclusion of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="s7">
<title>Ethics statement</title>
<p>The animal study was approved by the Institutional Ethics Committee (SUB/IAEC/12.01) approved all experimental protocols. The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec id="s8">
<title>Author contributions</title>
<p>UJ: Data curation, Writing&#x2013;original draft. HE-N: Supervision, Writing&#x2013;review and editing. AA: Formal Analysis, Writing&#x2013;original draft. MB: Formal Analysis, Writing&#x2013;original draft. IS: Formal Analysis, Writing&#x2013;original draft. SA: Formal Analysis, Writing&#x2013;original draft. FA: Visualization, Writing&#x2013;review and editing. NS: Funding acquisition, Project administration, Writing&#x2013;original draft. ME-S: Supervision, Writing&#x2013;review and editing. MI: Project administration, Supervision, Writing&#x2013;review and editing.</p>
</sec>
<sec sec-type="funding-information" id="s9">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was financially supported by United Arab Emirates University (Grant &#x23; 12S106 and SURE&#x002B;2023).</p>
</sec>
<ack>
<p>The authors are thankful to the Department of Pharmacy, Southern University Bangladesh for providing laboratory facilities and hosting this project.</p>
</ack>
<sec sec-type="COI-statement" id="s10">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s11">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abdelazim</surname>
<given-names>E. B.</given-names>
</name>
<name>
<surname>Abed</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Goher</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Alya</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>El-Nashar</surname>
<given-names>H. A.</given-names>
</name>
<name>
<surname>El-Moslamy</surname>
<given-names>S. H.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>
<italic>In vitro</italic> and <italic>in vivo</italic> studies of Syzygium cumini-loaded electrospun PLGA/PMMA/collagen nanofibers for accelerating topical wound healing</article-title>. <source>RSC Adv.</source> <volume>14</volume>, <fpage>101</fpage>&#x2013;<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1039/d3ra06355k</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abd Nikfarjam</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Adineh</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hajiali</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Nassiri-Asl</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Treatment with rutin-a therapeutic strategy for neutrophil-mediated inflammatory and autoimmune diseases:-anti-inflammatory effects of rutin on neutrophils</article-title>. <source>J. pharmacopuncture</source> <volume>20</volume>, <fpage>52</fpage>&#x2013;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.3831/KPI.2017.20.003</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Agatonovic-Kustrin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Morton</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mizaton</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zakaria</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>The relationship between major polyphenolic acids and stigmasterol to antioxidant activity in different extracts of Myrmecodia platytyrea</article-title>. <source>South Afr. J. Bot.</source> <volume>115</volume>, <fpage>94</fpage>&#x2013;<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1016/j.sajb.2017.12.011</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahmed</surname>
<given-names>O. M.</given-names>
</name>
<name>
<surname>Elkomy</surname>
<given-names>M. H.</given-names>
</name>
<name>
<surname>Fahim</surname>
<given-names>H. I.</given-names>
</name>
<name>
<surname>Ashour</surname>
<given-names>M. B.</given-names>
</name>
<name>
<surname>Naguib</surname>
<given-names>I. A.</given-names>
</name>
<name>
<surname>Alghamdi</surname>
<given-names>B. S.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Rutin and quercetin counter doxorubicin-induced liver toxicity in wistar rats via their modulatory effects on inflammation, oxidative stress, apoptosis, and Nrf2</article-title>. <source>Oxid. Med. Cell Longev.</source> <volume>2022</volume>, <fpage>2710607</fpage>. <pub-id pub-id-type="doi">10.1155/2022/2710607</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aruoma</surname>
<given-names>O. I.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Free radicals, oxidative stress, and antioxidants in human health and disease</article-title>. <source>J. Am. Oil Chem. Soc.</source> <volume>75</volume>, <fpage>199</fpage>&#x2013;<lpage>212</lpage>. <pub-id pub-id-type="doi">10.1007/s11746-998-0032-9</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ashmawy</surname>
<given-names>N. S.</given-names>
</name>
<name>
<surname>Gad</surname>
<given-names>H. A.</given-names>
</name>
<name>
<surname>El-Nashar</surname>
<given-names>H. A.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Comparative study of essential oils from different organs of syzygium cumini (pamposia) based on GC/MS chemical profiling and <italic>in vitro</italic> antiaging activity</article-title>. <source>Molecules</source> <volume>28</volume>, <fpage>7861</fpage>. <pub-id pub-id-type="doi">10.3390/molecules28237861</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Atanasov</surname>
<given-names>A. G.</given-names>
</name>
<name>
<surname>Zotchev</surname>
<given-names>S. B.</given-names>
</name>
<name>
<surname>Dirsch</surname>
<given-names>V. M.</given-names>
</name>
<name>
<surname>Supuran</surname>
<given-names>C. T.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Natural products in drug discovery: advances and opportunities</article-title>. <source>Nat. Rev. Drug Discov.</source> <volume>20</volume>, <fpage>200</fpage>&#x2013;<lpage>216</lpage>. <pub-id pub-id-type="doi">10.1038/s41573-020-00114-z</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Augustin</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Medico potential ferns of angamaly region, ernakulam district Kerala, India</article-title>. <source>Int. J. Curr. Pharm. Clin. Res.</source> <volume>5</volume>, <fpage>207</fpage>&#x2013;<lpage>211</lpage>. <pub-id pub-id-type="doi">10.1590/1519-6984.250256</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bakrim</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Benkhaira</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Bourais</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Benali</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>L.-H.</given-names>
</name>
<name>
<surname>El Omari</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Health benefits and pharmacological properties of stigmasterol</article-title>. <source>Antioxidants</source> <volume>11</volume>, <fpage>1912</fpage>. <pub-id pub-id-type="doi">10.3390/antiox11101912</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ballard</surname>
<given-names>T. S.</given-names>
</name>
<name>
<surname>Mallikarjunan</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>O&#x27;Keefe</surname>
<given-names>S. F.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Optimizing the extraction of phenolic antioxidants from peanut skins using response surface methodology</article-title>. <source>J. Agric. Food Chem.</source> <volume>57</volume>, <fpage>3064</fpage>&#x2013;<lpage>3072</lpage>. <pub-id pub-id-type="doi">10.1021/jf8030925</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bari</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Bhuiyan</surname>
<given-names>M. M. U.</given-names>
</name>
<name>
<surname>Khatun</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mitu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Khandokar</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Antioxidant, anti-inflammatory, thrombolytic, and cytotoxic activities of Gynura nepalensis DC. and isolation of its steroid constituents</article-title>. <source>Indian J. Nat. Prod. Resour. (IJNPR)[Formerly Nat. Prod. Radiance (NPR)]</source> <volume>13</volume>, <fpage>329</fpage>&#x2013;<lpage>338</lpage>. <pub-id pub-id-type="doi">10.56042/ijnpr.v13i3.37833</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baskaran</surname>
<given-names>X. R.</given-names>
</name>
<name>
<surname>Geo Vigila</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S. Z.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>S. X.</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>W. B.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>A review of the use of pteridophytes for treating human ailments</article-title>. <source>J. Zhejiang Univ. Sci. B</source> <volume>19</volume>, <fpage>85</fpage>&#x2013;<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1631/jzus.B1600344</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Batool</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Aziz</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Iqbal</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Salahuddin</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>B. K.-H.</given-names>
</name>
<name>
<surname>Tabassum</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>
<italic>In vitro</italic> antioxidant and anti-cancer activities and phytochemical analysis of Commelina benghalensis L. root extracts</article-title>. <source>Asian Pac. J. Trop. Biomed.</source> <volume>10</volume>, <fpage>417</fpage>. <pub-id pub-id-type="doi">10.4103/2221-1691.290133</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benniamin</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Medicinal ferns of North Eastern India with special reference to Arunachal Pradesh</article-title>. <source>Indian J. Traditional Knowl.</source>, <fpage>516</fpage>&#x2013;<lpage>522</lpage>.</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhuia</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Chowdhury</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sonia</surname>
<given-names>F. A.</given-names>
</name>
<name>
<surname>Kamli</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Shaikh</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>El-Nashar</surname>
<given-names>H. A. S.</given-names>
</name>
<etal/>
</person-group> (<year>2023a</year>). <article-title>Anticancer potential of the plant-derived saponin gracillin: a comprehensive review of mechanistic approaches</article-title>. <source>Chem. Biodivers.</source> <volume>20</volume>, <fpage>e202300847</fpage>. <pub-id pub-id-type="doi">10.1002/cbdv.202300847</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhuia</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Rahaman</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Islam</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Bappi</surname>
<given-names>M. H.</given-names>
</name>
<name>
<surname>Sikder</surname>
<given-names>M. I.</given-names>
</name>
<name>
<surname>Hossain</surname>
<given-names>K. N.</given-names>
</name>
<etal/>
</person-group> (<year>2023b</year>). <article-title>Neurobiological effects of gallic acid: current perspectives</article-title>. <source>Chin. Med.</source> <volume>18</volume>, <fpage>27</fpage>. <pub-id pub-id-type="doi">10.1186/s13020-023-00735-7</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhuia</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Wilairatana</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ferdous</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chowdhury</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bappi</surname>
<given-names>M. H.</given-names>
</name>
<name>
<surname>Rahman</surname>
<given-names>M. A.</given-names>
</name>
<etal/>
</person-group> (<year>2023c</year>). <article-title>Hirsutine, an emerging natural product with promising therapeutic benefits: a systematic review</article-title>. <source>Molecules</source> <volume>28</volume>, <fpage>6141</fpage>. <pub-id pub-id-type="doi">10.3390/molecules28166141</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Budge</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kaloriti</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Tillmann</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jacobsen</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Stress adaptation in a pathogenic fungus</article-title>. <source>J. Exp. Biol.</source> <volume>217</volume>, <fpage>144</fpage>&#x2013;<lpage>155</lpage>. <pub-id pub-id-type="doi">10.1242/jeb.088930</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Orally delivered rutin in lipid-based nano-formulation exerts strong antithrombotic effects by protein disulfide isomerase inhibition</article-title>. <source>Drug Deliv.</source> <volume>29</volume>, <fpage>1824</fpage>&#x2013;<lpage>1835</lpage>. <pub-id pub-id-type="doi">10.1080/10717544.2022.2083726</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Reactive oxygen species: key regulators in vascular health and diseases</article-title>. <source>Br. J. Pharmacol.</source> <volume>175</volume>, <fpage>1279</fpage>&#x2013;<lpage>1292</lpage>. <pub-id pub-id-type="doi">10.1111/bph.13828</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chik</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Or</surname>
<given-names>T. C.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Lau</surname>
<given-names>A. S.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Pharmacological effects of active compounds on neurodegenerative disease with gastrodia and uncaria decoction, a commonly used poststroke decoction</article-title>. <source>ScientificWorldJournal</source> <volume>2013</volume>, <fpage>896873</fpage>. <pub-id pub-id-type="doi">10.1155/2013/896873</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chowdhary</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Verma</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Pande</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Antioxidative properties of flavonoids from Cheilanthes anceps Swartz</article-title>. <source>J. Am. Sci.</source> <volume>6</volume>, <fpage>203</fpage>&#x2013;<lpage>207</lpage>. <pub-id pub-id-type="doi">10.1016/j.sjbs.2020.06.006</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="confproc">
<person-group person-group-type="author">
<name>
<surname>Daryono</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Rhomawati</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2020</year>). &#x201c;<article-title>An examination of medicinal potential of Pneumatopteris callosa: phytochemical screening, antibacterial, and antioxidant activity</article-title>,&#x201d; in <conf-name>IOP Conference Series: Earth and Environmental Science</conf-name> (<publisher-loc>Malang, Indonesia</publisher-loc>: <publisher-name>IOP Publishing</publisher-name>).<volume>456</volume>. <fpage>012068</fpage>.</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dharmadeva</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Galgamuwa</surname>
<given-names>L. S.</given-names>
</name>
<name>
<surname>Prasadinie</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kumarasinghe</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>
<italic>In vitro</italic> anti-inflammatory activity of Ficus racemosa L. bark using albumin denaturation method</article-title>. <source>Ayu</source> <volume>39</volume>, <fpage>239</fpage>&#x2013;<lpage>242</lpage>. <pub-id pub-id-type="doi">10.4103/ayu.AYU_27_18</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>El-Nashar</surname>
<given-names>H. A. S.</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Salem</surname>
<given-names>Y. H.</given-names>
</name>
</person-group> (<year>2023a</year>). <article-title>Genus pimenta: an updated comprehensive review on botany, distribution, ethnopharmacology, phytochemistry and biological approaches</article-title>. <source>Chem. Biodivers.</source> <volume>20</volume>, <fpage>e202300855</fpage>. <pub-id pub-id-type="doi">10.1002/cbdv.202300855</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>El-Nashar</surname>
<given-names>H. A. S.</given-names>
</name>
<name>
<surname>El-Din</surname>
<given-names>M. I. G.</given-names>
</name>
<name>
<surname>Hritcu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Eldahshan</surname>
<given-names>O. A.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Insights on the inhibitory power of flavonoids on tyrosinase activity: a survey from 2016 to 2021</article-title>. <source>Molecules</source> <volume>26</volume>, <fpage>7546</fpage>. <pub-id pub-id-type="doi">10.3390/molecules26247546</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>El-Nashar</surname>
<given-names>H. A. S.</given-names>
</name>
<name>
<surname>Sayed</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>El-Sherief</surname>
<given-names>H. A. M.</given-names>
</name>
<name>
<surname>Rateb</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Akil</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Khadra</surname>
<given-names>I.</given-names>
</name>
<etal/>
</person-group> (<year>2023b</year>). <article-title>Metabolomic profile, anti-trypanosomal potential and molecular docking studies of Thunbergia grandifolia</article-title>. <source>J. Enzyme Inhib. Med. Chem.</source> <volume>38</volume>, <fpage>2199950</fpage>. <pub-id pub-id-type="doi">10.1080/14756366.2023.2199950</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>El-Nashar</surname>
<given-names>H. A. S.</given-names>
</name>
<name>
<surname>Taleb</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>El-Shazly</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Farag</surname>
<given-names>M. A.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Polysaccharides (pectin, mucilage, and fructan inulin) and their fermented products: a critical analysis of their biochemical, gut interactions, and biological functions as antidiabetic agents</article-title>. <source>Phytother. Res.</source> <volume>38</volume>, <fpage>662</fpage>&#x2013;<lpage>693</lpage>. <pub-id pub-id-type="doi">10.1002/ptr.8067</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>El-Shawi</surname>
<given-names>O. E.</given-names>
</name>
<name>
<surname>El-Nashar</surname>
<given-names>H. A. S.</given-names>
</name>
<name>
<surname>Abd El-Rahman</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Eldahshan</surname>
<given-names>O. A.</given-names>
</name>
<name>
<surname>Singab</surname>
<given-names>A. N. B.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Protective effect of acrocarpus fraxinifolius extract against hepatic fibrosis induced by Gamma irradiation and carbon tetrachloride in albino rats</article-title>. <source>Int. J. Radiat. Biol.</source> <volume>99</volume>, <fpage>270</fpage>&#x2013;<lpage>280</lpage>. <pub-id pub-id-type="doi">10.1080/09553002.2022.2087926</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Forman</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Targeting oxidative stress in disease: promise and limitations of antioxidant therapy</article-title>. <source>Nat. Rev. Drug Discov.</source> <volume>20</volume>, <fpage>689</fpage>&#x2013;<lpage>709</lpage>. <pub-id pub-id-type="doi">10.1038/s41573-021-00233-1</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>French</surname>
<given-names>G. L.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Clinical impact and relevance of antibiotic resistance</article-title>. <source>Adv. Drug Deliv. Rev.</source> <volume>57</volume>, <fpage>1514</fpage>&#x2013;<lpage>1527</lpage>. <pub-id pub-id-type="doi">10.1016/j.addr.2005.04.005</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghorpade</surname>
<given-names>P. N.</given-names>
</name>
<name>
<surname>Thakar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dongare</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kale</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Phytochemical analysis of four Cheilanthes species from northern western ghats of India</article-title>. <source>RJLBPCS</source> <volume>1</volume>, <fpage>92</fpage>. <pub-id pub-id-type="doi">10.26479/2015.0102.04</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ginwala</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bhavsar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Chigbu</surname>
<given-names>D. I.</given-names>
</name>
<name>
<surname>Jain</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>Z. K.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Potential role of flavonoids in treating chronic inflammatory diseases with a special focus on the anti-inflammatory activity of apigenin</article-title>. <source>Antioxidants (Basel)</source> <volume>8</volume>, <fpage>35</fpage>. <pub-id pub-id-type="doi">10.3390/antiox8020035</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gunathilake</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ranaweera</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Rupasinghe</surname>
<given-names>H. P. V.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Change of phenolics, carotenoids, and antioxidant capacity following simulated gastrointestinal digestion and dialysis of selected edible green leaves</article-title>. <source>Food Chem.</source> <volume>245</volume>, <fpage>371</fpage>&#x2013;<lpage>379</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodchem.2017.10.096</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hanum</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Hamzah</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>The use of medicinal plant species by the temuan tribe of ayer hitam forest, selangor, peninsular Malaysia</article-title>. <source>Pertanika J. Trop. Agric. Sci.</source> <volume>22</volume>, <fpage>85</fpage>&#x2013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1080/09735070.2011.11886406</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ishaq</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>El-Nashar</surname>
<given-names>H. A. S.</given-names>
</name>
<name>
<surname>Younis</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Mangat</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Shahzadi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ul Haq</surname>
<given-names>A. S.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Genus Lupinus (Fabaceae): a review of ethnobotanical, phytochemical and biological studies</article-title>. <source>J. Pharm. Pharmacol.</source> <volume>74</volume>, <fpage>1700</fpage>&#x2013;<lpage>1717</lpage>. <pub-id pub-id-type="doi">10.1093/jpp/rgac058</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jamshidi-Kia</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Wibowo</surname>
<given-names>J. P.</given-names>
</name>
<name>
<surname>Elachouri</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Masumi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Salehifard-Jouneghani</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Abolhasanzadeh</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Battle between plants as antioxidants with free radicals in human body</article-title>. <source>J. Herbmed Pharmacol.</source> <volume>9</volume>, <fpage>191</fpage>&#x2013;<lpage>199</lpage>. <pub-id pub-id-type="doi">10.34172/jhp.2020.25</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jarial</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Shard</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Thakur</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sakinah</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zularisam</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rezania</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Characterization of flavonoids from fern Cheilanthes tenuifolia and evaluation of antioxidant, antimicrobial and anticancer activities</article-title>. <source>J. King Saud University-Science</source> <volume>30</volume>, <fpage>425</fpage>&#x2013;<lpage>432</lpage>. <pub-id pub-id-type="doi">10.1016/j.jksus.2017.04.007</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khalil</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Hafeez</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Malik</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Phenolic acid profiling by RP-HPLC: evaluation of antibacterial and anticancer activities of Conocarpus erectus plant extracts</article-title>. <source>Biol. Clin. Sci. Res. J.</source> <volume>2020</volume>. <pub-id pub-id-type="doi">10.54112/bcsrj.v2020i1.10</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Amin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mabkhot</surname>
<given-names>Y. N.</given-names>
</name>
<name>
<surname>Mubarak</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Hadda</surname>
<given-names>T. B.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Plant bioactive molecules bearing glycosides as lead compounds for the treatment of fungal infection: a review</article-title>. <source>Biomed. Pharmacother.</source> <volume>93</volume>, <fpage>498</fpage>&#x2013;<lpage>509</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2017.06.077</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Saeedi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nabavi</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Mubarak</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Bishayee</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Glycosides from medicinal plants as potential anticancer agents: emerging trends towards future drugs</article-title>. <source>Curr. Med. Chem.</source> <volume>26</volume>, <fpage>2389</fpage>&#x2013;<lpage>2406</lpage>. <pub-id pub-id-type="doi">10.2174/0929867325666180403145137</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>King</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>Fleming-Dutra</surname>
<given-names>K. E.</given-names>
</name>
<name>
<surname>Hicks</surname>
<given-names>L. A.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Advances in optimizing the prescription of antibiotics in outpatient settings</article-title>. <source>Bmj</source> <volume>363</volume>, <fpage>k3047</fpage>. <pub-id pub-id-type="doi">10.1136/bmj.k3047</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Landete</surname>
<given-names>J. M.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Dietary intake of natural antioxidants: vitamins and polyphenols</article-title>. <source>Crit. Rev. Food Sci. Nutr.</source> <volume>53</volume>, <fpage>706</fpage>&#x2013;<lpage>721</lpage>. <pub-id pub-id-type="doi">10.1080/10408398.2011.555018</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mahfuz</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Salam</surname>
<given-names>F. B. A.</given-names>
</name>
<name>
<surname>Deepa</surname>
<given-names>K. N.</given-names>
</name>
<name>
<surname>Hasan</surname>
<given-names>A. N.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Characterization of <italic>in-vitro</italic> antioxidant, cytotoxic, thrombolytic and membrane stabilizing potential of different extracts of Cheilanthes tenuifolia and Stigmasterol isolation from n-hexane extract</article-title>. <source>Clin. Phytoscience</source> <volume>5</volume>, <fpage>39</fpage>&#x2013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1186/s40816-019-0135-x</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin-Ventura</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Rodrigues-Diez</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Martinez-Lopez</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Salaices</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Blanco-Colio</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>Briones</surname>
<given-names>A. M.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Oxidative stress in human atherothrombosis: sources, markers and therapeutic targets</article-title>. <source>Int. J. Mol. Sci.</source> <volume>18</volume>, <fpage>2315</fpage>. <pub-id pub-id-type="doi">10.3390/ijms18112315</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mbaveng</surname>
<given-names>A. T.</given-names>
</name>
<name>
<surname>Ngameni</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kuete</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Simo</surname>
<given-names>I. K.</given-names>
</name>
<name>
<surname>Ambassa</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Roy</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>Antimicrobial activity of the crude extracts and five flavonoids from the twigs of Dorstenia barteri (Moraceae)</article-title>. <source>J. Ethnopharmacol.</source> <volume>116</volume>, <fpage>483</fpage>&#x2013;<lpage>489</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2007.12.017</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mia</surname>
<given-names>M. A. R.</given-names>
</name>
<name>
<surname>Dey</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Sakib</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Biswas</surname>
<given-names>M. Y.</given-names>
</name>
<name>
<surname>Prottay</surname>
<given-names>A. A. S.</given-names>
</name>
<name>
<surname>Paul</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>The efficacy of natural bioactive compounds against prostate cancer: molecular targets and synergistic activities</article-title>. <source>Phytotherapy Res.</source> <volume>37</volume>, <fpage>5724</fpage>&#x2013;<lpage>5754</lpage>. <pub-id pub-id-type="doi">10.1002/ptr.8017</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohsen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dickinson</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Somayaji</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Update on the adverse effects of antimicrobial therapies in community practice</article-title>. <source>Can. Fam. Physician</source> <volume>66</volume>, <fpage>651</fpage>&#x2013;<lpage>659</lpage>.</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moliner</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>L&#xf3;pez</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Barros</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Dias</surname>
<given-names>M. I.</given-names>
</name>
<name>
<surname>Ferreira</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Langa</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Rosemary flowers as edible plant foods: phenolic composition and antioxidant properties in <italic>Caenorhabditis elegans</italic>
</article-title>. <source>Antioxidants (Basel)</source> <volume>9</volume>, <fpage>811</fpage>. <pub-id pub-id-type="doi">10.3390/antiox9090811</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morimoto</surname>
<given-names>B. H.</given-names>
</name>
<name>
<surname>Castelloe</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Fox</surname>
<given-names>A. W.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Safety pharmacology in drug discovery and development</article-title>. <source>Princ. Saf. Pharmacol.</source> <volume>229</volume>, <fpage>65</fpage>&#x2013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-662-46943-9_3</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patel</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Reddy</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Cheilanthes tenuifolia (burm. F.) sw.(pteridaceae): a new record of fern for Gujarat, India</article-title>. <source>Adv. Bioresearch</source> <volume>9</volume>, <fpage>48</fpage>&#x2013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1080/23818107.2019.1636405</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prasad</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kashyap</surname>
<given-names>R. S.</given-names>
</name>
<name>
<surname>Deopujari</surname>
<given-names>J. Y.</given-names>
</name>
<name>
<surname>Purohit</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Taori</surname>
<given-names>G. M.</given-names>
</name>
<name>
<surname>Daginawala</surname>
<given-names>H. F.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Development of an <italic>in vitro</italic> model to study clot lysis activity of thrombolytic drugs</article-title>. <source>Thromb. J.</source> <volume>4</volume>, <fpage>14</fpage>. <pub-id pub-id-type="doi">10.1186/1477-9560-4-14</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rekatsina</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Paladini</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Piroli</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zis</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Pergolizzi</surname>
<given-names>J. V.</given-names>
</name>
<name>
<surname>Varrassi</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Pathophysiology and therapeutic perspectives of oxidative stress and neurodegenerative diseases: a narrative review</article-title>. <source>Adv. Ther.</source> <volume>37</volume>, <fpage>113</fpage>&#x2013;<lpage>139</lpage>. <pub-id pub-id-type="doi">10.1007/s12325-019-01148-5</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodr&#xed;guez-Yoldi</surname>
<given-names>M. J.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Anti-inflammatory and antioxidant properties of plant extracts</article-title>. <source>Antioxidants (Basel)</source> <volume>10</volume>, <fpage>921</fpage>. <pub-id pub-id-type="doi">10.3390/antiox10060921</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salatino</surname>
<given-names>M. L. F.</given-names>
</name>
<name>
<surname>Prado</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Flavonoid glycosides of Pteridaceae from Brazil</article-title>. <source>Biochem. Syst. Ecol.</source> <volume>26</volume>, <fpage>761</fpage>&#x2013;<lpage>769</lpage>. <pub-id pub-id-type="doi">10.1016/s0305-1978(98)00032-5</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salvamani</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gunasekaran</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Shaharuddin</surname>
<given-names>N. A.</given-names>
</name>
<name>
<surname>Ahmad</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Shukor</surname>
<given-names>M. Y.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Antiartherosclerotic effects of plant flavonoids</article-title>. <source>Biomed. Res. Int.</source> <volume>2014</volume>, <fpage>480258</fpage>. <pub-id pub-id-type="doi">10.1155/2014/480258</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sen</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Mukhopadhyay</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>New report of vessel elements in Aleuritopteris and Cheilanthes</article-title>. <source>Taiwania</source> <volume>59</volume>, <fpage>231</fpage>&#x2013;<lpage>239</lpage>. <pub-id pub-id-type="doi">10.6165/tai.2014.59.231</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shill</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>El-Nashar</surname>
<given-names>H. A.</given-names>
</name>
<name>
<surname>Mollick</surname>
<given-names>P. P.</given-names>
</name>
<name>
<surname>Acharyya</surname>
<given-names>R. N.</given-names>
</name>
<name>
<surname>Afrin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hossain</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Longevity spinach (Gynura procumbens) ameliorated oxidative stress and inflammatory mediators in cisplatin&#x2010;induced organ dysfunction in rats: comprehensive <italic>in vivo</italic> and <italic>in silico</italic> studies</article-title>. <source>Chem. Biodivers.</source>, <fpage>e202301719</fpage>. <pub-id pub-id-type="doi">10.1002/cbdv.202301719</pub-id>
</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shinde</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Phadke</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nair</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mungantiwar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Dikshit</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Saraf</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Membrane stabilizing activity&#x2014;a possible mechanism of action for the anti-inflammatory activity of Cedrus deodara wood oil</article-title>. <source>Fitoterapia</source> <volume>70</volume>, <fpage>251</fpage>&#x2013;<lpage>257</lpage>. <pub-id pub-id-type="doi">10.1016/s0367-326x(99)00030-1</pub-id>
</citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>B. P.</given-names>
</name>
<name>
<surname>Upadhyay</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Medicinal pteridophytes of Madhya Pradesh</article-title>. <source>J. Pharmacogn. Phytochemistry</source> <volume>3</volume>, <fpage>173</fpage>&#x2013;<lpage>176</lpage>.</citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tabassum</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ahmad</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rehman Khan</surname>
<given-names>K. u.</given-names>
</name>
<name>
<surname>Tabassum</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Khursheed</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zaman</surname>
<given-names>Q. U.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Phytochemical profiling, antioxidant, anti-inflammatory, thrombolytic, hemolytic activity <italic>in vitro</italic> and <italic>in silico</italic> potential of Portulacaria afra</article-title>. <source>Molecules</source> <volume>27</volume>, <fpage>2377</fpage>. <pub-id pub-id-type="doi">10.3390/molecules27082377</pub-id>
</citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thangjam</surname>
<given-names>N. M.</given-names>
</name>
<name>
<surname>Taijong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Phytochemical and pharmacological activities of methanol extract of Artemisia vulgaris L. leaves</article-title>. <source>Clin. Phytoscience</source> <volume>6</volume>, <fpage>72</fpage>&#x2013;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1186/s40816-020-00214-8</pub-id>
</citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thomford</surname>
<given-names>N. E.</given-names>
</name>
<name>
<surname>Senthebane</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Rowe</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Munro</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Seele</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Maroyi</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Natural products for drug discovery in the 21st century: innovations for novel drug discovery</article-title>. <source>Int. J. Mol. Sci.</source> <volume>19</volume>, <fpage>1578</fpage>. <pub-id pub-id-type="doi">10.3390/ijms19061578</pub-id>
</citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tlili</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Elfalleh</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Hannachi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yahia</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Khaldi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ferchichi</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Screening of natural antioxidants from selected medicinal plants</article-title>. <source>Int. J. food Prop.</source> <volume>16</volume>, <fpage>1117</fpage>&#x2013;<lpage>1126</lpage>. <pub-id pub-id-type="doi">10.1080/10942912.2011.576360</pub-id>
</citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Touati</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Saidani</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Boudries</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hammiche</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ouazene</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Bedjou</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Antibacterial activity of phenolic compounds of Pulicaria odora, wild plant in northern Algeria</article-title>. <source>Int. Food Res. J.</source> <volume>25</volume>, <fpage>2021</fpage>&#x2013;<lpage>2030</lpage>.</citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uddin</surname>
<given-names>M. Z.</given-names>
</name>
<name>
<surname>Rana</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Hossain</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ferdous</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dutta</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Dutta</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>
<italic>In vivo</italic> neuroprotective, antinociceptive, anti-inflammatory potential in Swiss albino mice and <italic>in vitro</italic> antioxidant and clot lysis activities of fractionated Holigarna longifolia Roxb. bark extract</article-title>. <source>J. Complementary Integr. Med.</source> <volume>17</volume>, <fpage>20190102</fpage>. <pub-id pub-id-type="doi">10.1515/jcim-2019-0102</pub-id>
</citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wen</surname>
<given-names>M.-C.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>C.-H.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Z.-Q.</given-names>
</name>
<name>
<surname>Srivastava</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ko</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xi</surname>
<given-names>S.-T.</given-names>
</name>
<etal/>
</person-group> (<year>2005</year>). <article-title>Efficacy and tolerability of antiasthma herbal medicine intervention in adult patients with moderate-severe allergic asthma</article-title>. <source>J. allergy Clin. Immunol.</source> <volume>116</volume>, <fpage>517</fpage>&#x2013;<lpage>524</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2005.05.029</pub-id>
</citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yonathan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Asres</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Assefa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bucar</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>
<italic>In vivo</italic> anti-inflammatory and anti-nociceptive activities of Cheilanthes farinosa</article-title>. <source>J. Ethnopharmacol.</source> <volume>108</volume>, <fpage>462</fpage>&#x2013;<lpage>470</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2006.06.006</pub-id>
</citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Younis</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Jabeen</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Hussain</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rasool</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Raza Ishaq</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nawaz</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Antioxidant and pulmonary protective potential of fraxinus xanthoxyloides bark extract against CCl(4) -induced toxicity in rats</article-title>. <source>Chem. Biodivers.</source> <volume>20</volume>, <fpage>e202200755</fpage>. <pub-id pub-id-type="doi">10.1002/cbdv.202200755</pub-id>
</citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zaragoza</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Monserrat</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mantecon</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Villaescusa</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>&#xc1;lvarez-Mon</surname>
<given-names>M. &#xc1;.</given-names>
</name>
<name>
<surname>Zaragoza</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Binding and antiplatelet activity of quercetin, rutin, diosmetin, and diosmin flavonoids</article-title>. <source>Biomed. Pharmacother.</source> <volume>141</volume>, <fpage>111867</fpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2021.111867</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>